var title_f17_42_18080="Intest transplant children";
var content_f17_42_18080=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 627px\">",
"   <div class=\"ttl\">",
"    Indication for intestinal transplantation in children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 607px; height: 383px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: the Intestinal Transplant Registry, Final Summary 2003. Reproduced with permission from David Grant, MD. file://www.intestinaltransplant.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18080=[""].join("\n");
var outline_f17_42_18080=null;
var title_f17_42_18081="Acyclovir (ophthalmic): International drug information";
var content_f17_42_18081=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Acyclovir (ophthalmic): International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10328829\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Zovirax Eye Ointment (SA)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10328830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiviral Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F10328988\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of herpes simplex keratitis",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F10328990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults: Topical: Apply 1 cm ribbon inside lower eyelid every 4 hours 5 times/day for 14 days or at least 3 days after healing is complete (whichever is shorter)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children: Refer to adult dosing",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F10328991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ointment, ophthalmic: 3% (4.5 g tube)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16448 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.167.4.114-B39C775BF0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18081=[""].join("\n");
var outline_f17_42_18081=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10328829\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10328830\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10328988\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10328990\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821254\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10328991\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/16448\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/16448|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?36/40/37512?source=related_link\">",
"      Acyclovir (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?37/48/38660?source=related_link\">",
"      Acyclovir (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/37/2649?source=related_link\">",
"      Acyclovir (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?1/27/1460?source=related_link\">",
"      Acyclovir (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?39/60/40899?source=related_link\">",
"      Acyclovir (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/51/9011?source=related_link\">",
"      Acyclovir (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_42_18082="Tinnitus (ringing in the ears)";
var content_f17_42_18082=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Tinnitus (ringing in the ears) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?17/42/18082/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18082/contributors\" id=\"au5311\">",
"       Elizabeth A Dinces, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?17/42/18082/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18082/contributors\" id=\"se6695\">",
"       Daniel G Deschler, MD, FACS",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?17/42/18082/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18082/contributors\" id=\"de8761\">",
"       Fenny H Lin, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?17/42/18082?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      TINNITUS OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Tinnitus is the perception of a ringing, buzzing, hissing, or roaring sound in one or both ears. It may be continuous or intermittent (occasional), can be pulsing or steady, and can range in severity from a soft buzz to a loud ring.",
"    </p>",
"    <p>",
"     It is estimated that as many as 50 million people in the United States suffer from chronic tinnitus (lasting longer than six months) [",
"     <a class=\"abstract\" href=\"UTD.htm?17/42/18082/abstract/1\">",
"      1",
"     </a>",
"     ]; about a quarter of those have tinnitus that is severe enough to interfere with daily activities. Tinnitus is more common in men than women, and it becomes more common with aging [",
"     <a class=\"abstract\" href=\"UTD.htm?17/42/18082/abstract/2,3\">",
"      2,3",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     Although tinnitus can be annoying, it is not usually a sign of a serious problem. There are ways to mask and adapt to the symptoms to minimize the impact of tinnitus on daily life.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      TINNITUS CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     Tinnitus is often caused by damage to the tiny hairs on auditory cells within the inner ear (",
"     <a class=\"graphic graphic_figure graphicRef73491 \" href=\"UTD.htm?2/31/2549\">",
"      figure 1",
"     </a>",
"     ). When the cells are damaged or stressed, they change the signal they send to the brain. Sometimes this produces a noise heard only by the patient. Damage to the hair cells can be a result of normal aging, or it can occur after exposure to very loud noise, certain medications, injury, or disease. Sometimes the damage is temporary but the noise is permanent.",
"    </p>",
"    <p>",
"     Occasionally tinnitus can be a result of problems not related to the hearing system. Disorders of the jaw joint (called the temporomandibular joint), severe anxiety, and neck injuries can cause tinnitus.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Age-related hearing loss",
"     </span>",
"     &nbsp;&mdash;&nbsp;Normal hearing loss often occurs with advancing age and is frequently accompanied by tinnitus.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Noise-induced hearing loss",
"     </span>",
"     &nbsp;&mdash;&nbsp;Prolonged exposure to excessively loud noise (eg, from chainsaws, gunfire, or even loud music) may lead to temporary or permanent hearing loss and tinnitus. A short blast of loud noise also can cause severe to profound hearing loss, pain, or hyperacusis (abnormal sensitivity to noise).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Other causes of auditory system dysfunction",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are many auditory problems that can lead to hearing loss and tinnitus. These include use of certain medications, stiffening of the bones in the middle ear (otosclerosis), tumors within the auditory system, blood vessels or neurologic disorders, and genetic or inherited inner ear disorders.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      TINNITUS SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     A high-pitched steady tone (ringing) is the most common form of tinnitus. Other symptoms can include a pulsation that is rushing or humming and varies in intensity with exercise or changing of body position. A clicking sound may indicates a nerve or muscle abnormality.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      TINNITUS DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     It is important for anyone with tinnitus to be evaluated to ensure that there is not another, more serious problem. In addition, anyone with severe or worsening and continuous ringing, buzzing, or other noises in the ear should be evaluated. Other specialized tests may be recommended.",
"    </p>",
"    <p>",
"     Hearing tests can help provide more information about the potential cause of tinnitus. Other tests, such as brain imaging with magnetic resonance imaging (MRI) or computed tomography (CT) scans may be needed, depending upon the results of the medical history and physical examination.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      TINNITUS MANAGEMENT",
"     </span>",
"    </p>",
"    <p>",
"     The management of tinnitus involves treating any underlying disorders or abnormalities (see",
"     <a class=\"local\" href=\"#H2\">",
"      'Tinnitus causes'",
"     </a>",
"     above) as well as addressing the tinnitus itself. Although there is no cure for most cases of chronic tinnitus, there are ways to manage the condition.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Treatment of underlying problems",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h3\">",
"      Hearing loss",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hearing aids may improve tinnitus symptoms in people with age-related hearing loss. Hearing aids work by making outside sounds clearer and louder, which may cause the tinnitus noise to be less noticeable. People with other causes of hearing loss may benefit from surgery to the outer or middle ear.",
"    </p>",
"    <p>",
"     Cochlear implants are devices that are implanted in the inner ear and use electrical stimulation to help improve hearing. They may be recommended for adults or children with severe to profound hearing loss who do not benefit from hearing aids. These implants may help relieve tinnitus in some cases; however, they are only available in selected cases and a full evaluation is required before consideration.",
"    </p>",
"    <p>",
"     In patients with auditory system damage due to use of medication, stopping the medication may improve tinnitus and prevent hearing loss from worsening. Patients should consult with a healthcare provider before starting or stopping any medications.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h3\">",
"      Depression",
"     </span>",
"     &nbsp;&mdash;&nbsp;Depression is common in people with tinnitus. Safe and effective treatments for depression are available and antidepressant medications may improve the symptoms of tinnitus in some people. Antidepressants can also improve a person's ability to cope with the problem. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=see_link\">",
"      \"Patient information: Depression in adults (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=see_link\">",
"      \"Patient information: Depression treatment options for adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h3\">",
"      Insomnia",
"     </span>",
"     &nbsp;&mdash;&nbsp;People who have difficulty sleeping as a result of tinnitus may be treated with medications",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     behavior changes to improve sleep. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/24/28035?source=see_link\">",
"      \"Patient information: Insomnia treatments (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Behavioral therapies",
"     </span>",
"     &nbsp;&mdash;&nbsp;A number of behavioral therapies can help a person to live with chronic tinnitus.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Tinnitus retraining therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Tinnitus retraining therapy (TRT) involves retraining the subconscious part of the auditory system to accept the sounds associated with tinnitus as normal, natural sounds rather than annoying sounds [",
"     <a class=\"abstract\" href=\"UTD.htm?17/42/18082/abstract/4\">",
"      4",
"     </a>",
"     ]. The goal is for the person to become unaware of their tinnitus unless they consciously choose to focus on it.",
"    </p>",
"    <p>",
"     TRT is performed by experts in a tinnitus center; it includes counseling as well as the use of a wearable device that emits low-level noise and environmental sounds. Although TRT has demonstrated short-term success in many tinnitus sufferers, it requires a commitment to the program; the noise-generating device may need to be worn for one to two years.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Masking",
"     </span>",
"     &nbsp;&mdash;&nbsp;Masking devices resemble hearing aids and produce low-level sounds, which help to reduce or eliminate the tinnitus noise in some patients [",
"     <a class=\"abstract\" href=\"UTD.htm?17/42/18082/abstract/5\">",
"      5",
"     </a>",
"     ]. Masking does not relieve tinnitus in all patients. Some people report a worsening of their tinnitus with masking. Those who do experience relief typically find that tinnitus returns after the masking device is removed.",
"    </p>",
"    <p>",
"     Patients can also achieve a lesser degree of masking by listening to quiet music or creating low background noise with a radio on low volume, a fan, a white noise machine, or pillow speakers. This may be especially helpful for people with tinnitus that is bothersome in quiet environments.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      Biofeedback and stress reduction",
"     </span>",
"     &nbsp;&mdash;&nbsp;Biofeedback is a relaxation technique that teaches a person to control certain body functions, such as heart and breathing rate. Biofeedback may help people to manage tinnitus-related distress by changing their reaction to it. Some people experience relief of tinnitus symptoms once they are able to stop thinking of their tinnitus as bothersome or stressful [",
"     <a class=\"abstract\" href=\"UTD.htm?17/42/18082/abstract/6\">",
"      6",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h3\">",
"      Cognitive behavioral therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;The goal of cognitive behavioral therapy (CBT) is to teach patients to manage their psychological responses to tinnitus. It involves using coping strategies, distraction skills, and relaxation techniques.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Other therapies",
"     </span>",
"     &nbsp;&mdash;&nbsp;A number of other types of treatments for tinnitus have been studied, although none have been found to reliably be more effective than placebo. Nevertheless, many tinnitus support groups have members who are helped by these treatments. Individual patients who respond may be experiencing a true benefit.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Electrical stimulation &mdash; Electrical stimulation of certain parts of the inner ear can be accomplished by placing electrodes on the skin or using acupuncture needles (see below). There are different modes of delivering electrical stimulation, depending on the patient's situation and other factors, such as whether hearing loss is present.",
"      </li>",
"      <li>",
"       Acupuncture &mdash; Acupuncture involves inserting hair-thin, metal needles into the skin at specific points on the body. It causes little to no pain. Acupuncture may be used alone or in combination with electric stimulation.",
"      </li>",
"      <li>",
"       Repetitive transcranial magnetic stimulation (rTMS) &mdash; During repetitive transcranial magnetic stimulation (rTMS), a powerful magnetic field is used to stimulate the brain.",
"      </li>",
"      <li>",
"       Herbal remedies &mdash; Combinations of herbs (also called botanicals) are often promoted as treatments for medical problems. Herbal medicines may come in the form of a powder, liquid, or pill. Ginkgo biloba and melatonin have both been studied for use in treating tinnitus.",
"      </li>",
"      <li>",
"       Vitamins and minerals &mdash; Vitamins and minerals that have been studied for treatment of tinnitus and inner-ear health include niacin (a B vitamin), zinc, and copper.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      PROGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     The impact of tinnitus on everyday life varies, often depending upon the severity of the tinnitus noise. About 25 percent of sufferers report an increase in tinnitus severity over time [",
"     <a class=\"abstract\" href=\"UTD.htm?17/42/18082/abstract/7\">",
"      7",
"     </a>",
"     ]. Long-term tinnitus is unlikely to go away completely. However, it often becomes less bothersome over time, especially when hearing loss is also present.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H20\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1784888007\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5395949\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/26/43425?source=see_link\">",
"      Patient information: Tinnitus (ringing in the ears) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/26/33186?source=see_link\">",
"      Patient information: Age-related hearing loss (presbycusis) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/46/32482?source=see_link\">",
"      Patient information: Ear wax impaction (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?26/10/26785?source=see_link\">",
"      Patient information: Labyrinthitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/10/40097?source=see_link\">",
"      Patient information: Meniere disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?43/20/44353?source=see_link\">",
"      Patient information: Vestibular schwannoma (acoustic neuroma) (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5395984\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=see_link\">",
"      Patient information: Depression in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=see_link\">",
"      Patient information: Depression treatment options for adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/24/28035?source=see_link\">",
"      Patient information: Insomnia treatments (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/6/26727?source=see_link\">",
"      Etiology and diagnosis of tinnitus",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/15/10490?source=see_link\">",
"      Etiology of hearing loss in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/32/39429?source=see_link\">",
"      Evaluation of hearing loss in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/24/39300?source=see_link\">",
"      Hearing amplification in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25495?source=see_link\">",
"      Treatment of tinnitus",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute on Deafness and Other Communication Disorders (NIDCD)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nidcd.nih.gov/health/hearing/noiseinear.asp\">",
"      www.nidcd.nih.gov/health/hearing/noiseinear.asp",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Otolaryngology - Head and Neck Surgery (AAOHNS)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.entnet.org/HealthInformation/tinnitus.cfm\">",
"      www.entnet.org/HealthInformation/tinnitus.cfm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Tinnitus Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.ata.org/\">",
"      www.ata.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The American Speech-Language-Hearing Association (ASHA)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.asha.org/public/hearing/disorders/Tinnitus.htm\">",
"      www.asha.org/public/hearing/disorders/Tinnitus.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The International Tinnitus Journal",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.tinnitusjournal.com/\">",
"      www.tinnitusjournal.com",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     UpToDate wishes to acknowledge Kelly Crowley for her contributions to this topic.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 19, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?17/42/18082?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     www.ata.org (Accessed on July 15, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18082/abstract/2\">",
"      Adams PF, Hendershot GE, Marano MA, Centers for Disease Control and Prevention/National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10 1999; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18082/abstract/3\">",
"      Ahmad N, Seidman M. Tinnitus in the older adult: epidemiology, pathophysiology and treatment options. Drugs Aging 2004; 21:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18082/abstract/4\">",
"      Jastreboff PJ, Gray WC, Gold SL. Neurophysiological approach to tinnitus patients. Am J Otol 1996; 17:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18082/abstract/5\">",
"      Vernon JA, Meikle MB. Masking devices and alprazolam treatment for tinnitus. Otolaryngol Clin North Am 2003; 36:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18082/abstract/6\">",
"      Andersson G, Lyttkens L. A meta-analytic review of psychological treatments for tinnitus. Br J Audiol 1999; 33:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18082/abstract/7\">",
"      Stouffer JL, Tyler RS. Characterization of tinnitus by tinnitus patients. J Speech Hear Disord 1990; 55:439.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f17_42_18082=[""].join("\n");
var outline_f17_42_18082=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           TINNITUS OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           TINNITUS CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           TINNITUS SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           TINNITUS DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           TINNITUS MANAGEMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           PROGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H20\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/31/2549\" title=\"figure 1\">",
"           Tinnitus PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f17_42_18083="Communicating hydrocele 2";
var content_f17_42_18083=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F50831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F50831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Communicating hydrocele",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 274px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Communicating hydroceles usually develop as a result of failure of the processus vaginalis to close during development. The patent processus vaginalis is demonstrated in Panel B.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Laurence Baskin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18083=[""].join("\n");
var outline_f17_42_18083=null;
var title_f17_42_18084="Why does my child need vaccines?";
var content_f17_42_18084=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Why does my child need vaccines? (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?17/42/18084/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18084/contributors\" id=\"au4584\">",
"       Jan E Drutz, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?17/42/18084/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18084/contributors\" id=\"se4794\">",
"       Teresa K Duryea, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?17/42/18084/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18084/contributors\" id=\"de5754\">",
"       Mary M Torchia, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?17/42/18084?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     Vaccines are one of the most effective ways to prevent serious illness in children and adults. Vaccine programs in the United States have been quite successful in reducing the number of children affected by many highly contagious diseases, including measles, rubella, mumps, diphtheria, and polio.",
"    </p>",
"    <p>",
"     The following is a discussion of how immunizations work, common side effects, reasons to avoid a particular vaccine, and common concerns about vaccines. Separate articles discuss individual vaccines for children and adults. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/36/42566?source=see_link\">",
"      \"Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/18/37156?source=see_link\">",
"      \"Patient information: Vaccines for children age 7 to 18 years (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/25/39318?source=see_link\">",
"      \"Patient information: Adult vaccines (Beyond the Basics)\"",
"     </a>",
"     .).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      HOW DO VACCINES WORK?",
"     </span>",
"    </p>",
"    <p>",
"     The immune system functions to protect the body against illness and infection. When an organism (bacterium or virus) is foreign to the body, the immune system detects the organism and responds by creating proteins called antibodies. Antibodies fight the infection and help the person to recover.",
"    </p>",
"    <p>",
"     Antibodies also work to prevent a person from becoming ill in the future. If a person is exposed to the organism again, the immune system recognizes it and rapidly produces more of the antibodies required to destroy the organism. This response protects the individual from developing the disease, ideally for life. For example, a person who had chickenpox as a child is unlikely to develop it again, even if he or she is in close contact with a person who is infected.",
"    </p>",
"    <p>",
"     Vaccines work by stimulating the immune system to produce antibodies. However, unlike bacteria and viruses, vaccines do not cause the person to become ill in order to develop these antibodies. There are two main types of vaccines: active and passive.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Active vaccines",
"     </span>",
"     &nbsp;&mdash;&nbsp;Active vaccines use a weakened form of the harmful bacteria or virus to stimulate the immune system. Examples of active vaccines include vaccines that are used to prevent polio, measles, mumps, rubella (German measles), pertussis, etc.",
"    </p>",
"    <p>",
"     Some bacteria (eg, diphtheria, tetanus) cause illness because they produce harmful substances called toxins. Vaccines that help the immune system protect the body from toxins are called toxoids. Toxoids are made from weakened forms of the bacterial toxins.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Passive vaccines",
"     </span>",
"     &nbsp;&mdash;&nbsp;Passive vaccines provide temporary immunity using antibodies obtained from a large pool of donors; this type of preparation is known as immune serum globulin. Passive vaccines offer short-term protection to children or adults who have been exposed to a specific organism.",
"    </p>",
"    <p>",
"     One example of a passive vaccine is hepatitis B immune globulin (HBIG). HBIG is given to newborns whose mothers test positive for hepatitis B surface antigen (HBsAg). HBIG provides temporary protection to the newborn against infection with hepatitis B.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Vaccines protect children and adults",
"     </span>",
"     &nbsp;&mdash;&nbsp;Many parents are concerned about the risks of vaccines. However, vaccines have a long record of being a safe and effective way of preventing disease. In most cases, the benefits of vaccinating a child are far greater than any potential risks.",
"    </p>",
"    <p>",
"     Diseases such as diphtheria and measles were common at one time in the United States, but are no longer a significant threat because of vaccination programs. However, these illnesses are still common in developing countries throughout the world. Because it is easy to travel from one country to another, it is very possible for someone with a vaccine-preventable disease to enter the United States and transmit the disease to any child or adult who has not been vaccinated. Vaccination helps to reduce a child's, family's, and even an entire community's chances of becoming ill by decreasing the number of people who could get sick and then transmit the infection to others. This process of protection is sometimes referred to as \"herd immunity\".",
"    </p>",
"    <p>",
"     An example of a successful vaccination effort is the smallpox program. Before a vaccine was available, smallpox killed millions of people every year. Up until the early 1970s, smallpox disease was a worldwide threat to life. Use of the smallpox vaccine in large populations of people prior to the 1970s led to complete eradication of the disease. Because of this, the smallpox vaccination is no longer administered for routine protection.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      How are vaccines given?",
"     </span>",
"     &nbsp;&mdash;&nbsp;In children, most immunizations are given in the form of a shot. Vaccines are also given in other ways, such as in a liquid taken by mouth (eg, rotavirus) or as a nasal spray (eg, one form of the influenza vaccine).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Paying for vaccines",
"     </span>",
"     &nbsp;&mdash;&nbsp;Vaccines are available for every child in the United States, even for those who do not have health insurance. If a child does not have health insurance and the parents are unable to pay for vaccines, a program called",
"     <a class=\"external\" href=\"file://www.cdc.gov/vaccines/programs/vfc/default.htm\">",
"      Vaccines for Children",
"     </a>",
"     is available. This program helps to cover the costs of vaccines given at private doctor's offices, clinics, hospitals, community health clinics, and in some schools.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      VACCINE SIDE EFFECTS",
"     </span>",
"    </p>",
"    <p>",
"     Most vaccines and toxoids are safe and cause few if any serious side effects. Very rarely, serious side effects do occur. Children who develop unusual reactions such as rashes involving much of the body surface, difficulty breathing, excessively high fevers, seizures or loss of consciousness within a short time after receiving a vaccine should be evaluated by a healthcare provider.",
"    </p>",
"    <p>",
"     To report an unusual reaction after a vaccine, you can contact the national",
"     <a class=\"external\" href=\"file://vaers.hhs.gov/index\">",
"      Vaccine Adverse Event Reporting System",
"     </a>",
"     (VAERS, telephone number 1-800-822-7967). Parents who are concerned about a particular vaccine should discuss their concerns with their child's healthcare provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Mild side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Vaccines and toxoids can occasionally cause mild side effects, including:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       A low-grade fever",
"      </li>",
"      <li>",
"       A red and tender area at the site of an injection",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Moderate side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Occasionally, children can develop a combination of fever, skin rash, swollen lymph nodes,",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     joint pain after vaccination. These reactions, called serum sickness-like reactions, can be uncomfortable, although they are rarely dangerous and resolve without treatment in days to weeks.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Severe side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Severe side effects of vaccines are rare, but may include a severe neurologic reaction (eg, seizures) or severe allergic reactions (eg, anaphylaxis). Allergic reactions usually occur within minutes to hours of receiving the vaccine. If this occurs in the doctor&rsquo;s or nurse's office, emergency care can be given immediately. If a severe reaction occurs away from the doctor&rsquo;s or nurse&rsquo;s office, the",
"     <span class=\"nowrap\">",
"      parent/guardian",
"     </span>",
"     should call emergency medical services, available in most areas of the United States by dialing 911.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Reasons to avoid vaccination",
"     </span>",
"     &nbsp;&mdash;&nbsp;A particular vaccine may not be recommended for children with a serious allergic reaction to the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Eggs or egg protein, since some vaccines are prepared with embryonic chicken eggs or cultures (eg, influenza vaccines, yellow fever vaccines). A mild allergic reaction to eggs does",
"       <strong>",
"        not",
"       </strong>",
"       mean that the vaccine should be avoided.",
"      </li>",
"      <li>",
"       The antibiotic medications neomycin or streptomycin (some vaccines contains trace amounts of neomycin)",
"      </li>",
"      <li>",
"       Gelatin",
"      </li>",
"      <li>",
"       A specific vaccine administered in the past",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     In some cases, parents may not know their child is allergic to one of these components until the vaccine is given and the child develops a reaction.",
"    </p>",
"    <p>",
"     In addition, live virus vaccines (eg, the measles, mumps, and rubella vaccine) are generally not recommended for children with a weakened immune system since there is an increased risk of infection as a result of the vaccine. However, there may be exceptions to this recommendation.",
"    </p>",
"    <p>",
"     Administration of the measles-mumps-rubella and varicella vaccines should be delayed in children who have recently received a blood transfusion or blood products (eg, immunoglobulin preparations) since these products can make the vaccine less effective.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Conditions that do not affect vaccination",
"     </span>",
"     &nbsp;&mdash;&nbsp;The following conditions do not require delaying or avoiding vaccines:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Current or recent mild illness",
"      </li>",
"      <li>",
"       Current or recent antibiotic therapy",
"      </li>",
"      <li>",
"       Previous mild to moderate tenderness, redness, or swelling at the site of injection or fever less than 104.9&ordm;F (40.5&ordm;C) after a previous vaccination",
"      </li>",
"      <li>",
"       A personal history of allergies, except those listed above",
"      </li>",
"      <li>",
"       A family history of adverse reactions to vaccines",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Are vaccines safe for my child?",
"     </span>",
"     &nbsp;&mdash;&nbsp;There have been concerns about the safety of vaccines for children.",
"    </p>",
"    <p>",
"     One concern was related to a particular preservative (thimerosal) that was previously used in a number of different vaccines. The concern centered around the possibility of any relationship between the administration of certain vaccines and autism. Thimerosal is a derivative of mercury that was previously used as a preservative in most vaccines. As the number of vaccinations given to infants increased, there was concern that this preservative could lead to potentially unsafe levels of mercury levels in some infants. As a result, several expert groups recommended in 1999 that all standard childhood vaccines be produced without thimerosal. The recommendation was a precautionary change and was",
"     <strong>",
"      not",
"     </strong>",
"     based upon known harm from thimerosal. Thimerosal-free forms of all of the childhood vaccines are available in the United States. A large number of studies throughout the world have failed to show any cause and effect relationship between autism and those vaccines that contained thimerosal.",
"    </p>",
"    <p>",
"     A second concern was in regards to a possible relationship between certain vaccines and the development of autism. Despite this concern, there is no scientific evidence that receiving these vaccines causes or increases the risk of developing autism.",
"    </p>",
"    <p>",
"     Studies that had previously raised the possibility of a relationship had significant weaknesses in their design. A number of the studies were based on a small number of children and relied upon the memory of parents or pediatricians to recall when behavioral",
"     <span class=\"nowrap\">",
"      signs/symptoms",
"     </span>",
"     related to autism began. Most studies did not include a control group to compare children who were vaccinated with those who were not vaccinated to determine if there was a cause and effect relationship. At least some cases of autism are most likely attributable to gene abnormalities.",
"    </p>",
"    <p>",
"     For more information about any potential link between vaccines and autism, visit the",
"     <a class=\"external\" href=\"file://www.cdc.gov/vaccinesafety/Concerns/Autism/Index.html\">",
"      Centers for Disease Control and Prevention",
"     </a>",
"     .",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      VACCINE RECOMMENDATIONS",
"     </span>",
"    </p>",
"    <p>",
"     To prevent a child from getting any of the diseases for which vaccine protection is available, children should begin receiving vaccines within the first few months of life. This allows the child to be protected from common childhood illnesses as well as illnesses that can develop during adulthood.",
"    </p>",
"    <p>",
"     Many diseases prevented by vaccines are more serious in young children. Infants and children frequently seen by their healthcare provider during the first year of life are more likely to receive all of the recommended vaccines. In most states, specific vaccines are required before the child can attend school. This policy is designed to not only protect the individual child but to prevent the spread of certain contagious diseases to other children attending the school. Vaccine requirements tend to vary from state to state.",
"    </p>",
"    <p>",
"     In the United States, certain vaccines are recommended for children between birth and 6 years. The recommended schedule is available through the",
"     <a class=\"external\" href=\"file://www.cdc.gov/vaccines/parents/downloads/parent-ver-sch-0-6yrs.pdf\">",
"      Centers for Disease Control and Prevention",
"     </a>",
"     (CDC). Using combination vaccines can help to reduce the number of shots needed at each visit. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/36/42566?source=see_link\">",
"      \"Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     The timing of vaccines is important; some vaccines are most effective when given to children at a particular age or in combination with other vaccines. A personal, customized vaccine schedule is available through the",
"     <a class=\"external\" href=\"file://www2a.cdc.gov/nip/kidstuff/newscheduler_le/\">",
"      CDC",
"     </a>",
"     . The schedule may be helpful in reminding parents when their child is due for vaccines.",
"    </p>",
"    <p>",
"     The CDC has also developed a",
"     <a class=\"external\" href=\"https://www.vacscheduler.org/\">",
"      catch-up immunization scheduler",
"     </a>",
"     to help parents of children younger than six years determine which vaccines have been missed and when the vaccines should be scheduled for administration.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your child's healthcare provider is the best source of information for questions and concerns related to your child's medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2287478032\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11569974\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/48/12035?source=see_link\">",
"      Patient information: Vaccines (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/22/28003?source=see_link\">",
"      Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/7/18547?source=see_link\">",
"      Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/44/21187?source=see_link\">",
"      Patient information: Vaccines for travel (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/24/11650?source=see_link\">",
"      Patient information: Mumps (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/10/14499?source=see_link\">",
"      Patient information: Rubella (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/34/31266?source=see_link\">",
"      Patient information: Tetanus (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/57/8082?source=see_link\">",
"      Patient information: Poliomyelitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/56/2947?source=see_link\">",
"      Patient information: Measles (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/61/33746?source=see_link\">",
"      Patient information: Tdap vaccine (The Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11570032\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/36/42566?source=see_link\">",
"      Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/18/37156?source=see_link\">",
"      Patient information: Vaccines for children age 7 to 18 years (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/25/39318?source=see_link\">",
"      Patient information: Adult vaccines (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43097?source=see_link\">",
"      Allergic reactions to vaccines",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13480?source=see_link\">",
"      Clinical trials of human papillomavirus vaccines",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/61/8154?source=see_link\">",
"      Epidemiology, clinical manifestations, diagnosis and management of mumps",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=see_link\">",
"      Hepatitis A virus vaccination and postexposure prophylaxis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/60/31690?source=see_link\">",
"      Hepatitis B virus vaccination",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23050?source=see_link\">",
"      Meningococcal vaccines",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=see_link\">",
"      Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/52/17223?source=see_link\">",
"      Poliovirus vaccination",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/26/37289?source=see_link\">",
"      Prevention of varicella-zoster virus infection: Chickenpox",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=see_link\">",
"      Recommendations for the use of human papillomavirus vaccines",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26855?source=see_link\">",
"      Rubella",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/18/27946?source=see_link\">",
"      Seasonal influenza vaccination in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=see_link\">",
"      Standard immunizations for children and adolescents",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23110?source=see_link\">",
"      Treatment of varicella-zoster virus infection: Chickenpox",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/7/40057?source=see_link\">",
"      Vaccinia virus as the smallpox vaccine",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Allergy and Infectious Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.niaid.nih.gov/\">",
"      www.niaid.nih.gov/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Centers for Disease Control and Prevention (CDC) National Immunization Program",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 311-3435",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/vaccines/\">",
"      www.cdc.gov/vaccines/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Foundation for Infectious Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Tel: (301) 656-0003",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nfid.org/\">",
"      www.nfid.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The Children's Hospital of Philadelphia Vaccine Education Center",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.chop.edu/service/vaccine-education-center/home.html\">",
"      www.chop.edu/service/vaccine-education-center/home.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Vaccinate Your Baby",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.vaccinateyourbaby.com/\">",
"      www.vaccinateyourbaby.com",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?17/42/18084/abstract/1-5\">",
"      1-5",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 3, 2013.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?17/42/18084?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18084/abstract/1\">",
"      ACIP Childhood/Adolescent Immunization Work Group, Akinsanya-Beysolow I, Jenkins R, et al. Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for persons aged 0 through 18 years--United States, 2013. MMWR Surveill Summ 2013; 62 Suppl 1:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18084/abstract/2\">",
"      Feikin DR, Lezotte DC, Hamman RF, et al. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA 2000; 284:3145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18084/abstract/3\">",
"      Centers for Disease Control and Prevention (CDC). Summary of the joint statement on thimerosal in vaccines. American Academy of Family Physicians, American Academy of Pediatrics, Advisory Committee on Immunization Practices, Public Health Service. MMWR Morb Mortal Wkly Rep 2000; 49:622, 631.",
"     </a>",
"    </li>",
"    <li>",
"     Immunization Action Coalition. file://www.immunize.org/ (Accessed on May 24, 2012).",
"    </li>",
"    <li>",
"     Offit PA, Moser CA. Vaccines and Your Child: Separating Fact from Fiction, Columbia University Press, New York 2011.",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f17_42_18084=[""].join("\n");
var outline_f17_42_18084=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           HOW DO VACCINES WORK?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           VACCINE SIDE EFFECTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           VACCINE RECOMMENDATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f17_42_18085="Raloxifene: Patient drug information";
var content_f17_42_18085=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Raloxifene: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/15/6390?source=see_link\">",
"     see \"Raloxifene: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F217082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Evista&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F217083\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Raloxifene&reg;;",
"     </li>",
"     <li>",
"      Evista&reg;;",
"     </li>",
"     <li>",
"      Novo-Raloxifene;",
"     </li>",
"     <li>",
"      Teva-Raloxifene",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10016281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700778",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of a stroke or blood clots. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016283\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691539",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put off soft, brittle bones (osteoporosis) in women after change of life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop breast cancer in women after the change of life who have soft, brittle bones (osteoporosis) or those with more of a chance of getting breast cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702846",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to raloxifene or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703722",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have blood clots or have had blood clots in the past.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697271",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high triglycerides, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696863",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take colestipol or cholestyramine within 4 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696631",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid being still for long periods of time (long trips, bed rest after surgery). Not moving for long periods may raise your chance of blood clots. Go back to normal activity as soon as you can.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699092",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in the feet or hands.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698156",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hot flashes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698200",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Leg cramps.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016290\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698598",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A lump in the breast or breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699052",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696101",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug works best when used with calcium/vitamin D and weight-bearing workouts like walking or PT (physical therapy).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016291\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016292\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11017 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-188.40.116.55-6D8648E745-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18085=[""].join("\n");
var outline_f17_42_18085=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217082\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217083\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016281\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016283\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016282\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016287\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016288\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016290\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016285\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016286\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016291\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016292\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?6/15/6390?source=related_link\">",
"      Raloxifene: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_42_18086="Evaluation of epistaxis in children";
var content_f17_42_18086=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of epistaxis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/42/18086/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18086/contributors\">",
"     Anna H Messner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/42/18086/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18086/contributors\">",
"     Ellen M Friedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18086/contributors\">",
"     Jonathan I Singer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18086/contributors\">",
"     Glenn C Isaacson, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/42/18086/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18086/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/42/18086/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epistaxis is common in children. Childhood nosebleeds are rarely severe and seldom require hospital admission [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/1\">",
"     1",
"    </a>",
"    ]. Nonetheless, frequent minor nosebleeds can be both bothersome and alarming for parents and children.",
"   </p>",
"   <p>",
"    The evaluation of epistaxis in children will be reviewed here. The epidemiology, etiology, and management of epistaxis in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link\">",
"     \"Epidemiology and etiology of epistaxis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26536?source=see_link\">",
"     \"Management of epistaxis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although nosebleeds in children are rarely life threatening, the initial evaluation should focus upon the respiratory and hemodynamic stability of the patient rather than the bleeding. Normal appearance, vital signs, and respiratory function are evidence that the examiner can safely attend to the presenting complaint. On the other hand, abnormalities in these indices may signal an emergency. Airway intervention and fluid resuscitation are sometimes necessary in massive epistaxis. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Emergency treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The goal of the evaluation is to determine the site and etiology of bleeding. Nosebleeds in children have a variety of etiologies, ranging from self-limited mucosal irritation to life-threatening neoplasms (",
"    <a class=\"graphic graphic_table graphicRef67540 \" href=\"UTD.htm?17/47/18172\">",
"     table 1",
"    </a>",
"    ). Distinguishing between local and systemic causes of bleeding is critical to the institution of timely and appropriate therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link\">",
"     \"Epidemiology and etiology of epistaxis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26536?source=see_link\">",
"     \"Management of epistaxis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EMERGENCY TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid assessment of general appearance, vital signs, airway stability, and mental status are necessary to identify children with respiratory or hemodynamic instability who require airway intervention",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fluid resuscitation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Airway intervention is needed for patients who are spitting or regurgitating blood [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"     \"Emergent endotracheal intubation in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=see_link&amp;anchor=H13#H13\">",
"     \"Hypovolemic shock in children: Initial evaluation and management\", section on 'Fluid resuscitation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26536?source=see_link\">",
"     \"Management of epistaxis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rapid assessment and stabilization is followed immediately by attempts to identify the source of bleeding and initiation of measures to control it, usually in consultation with otolaryngology [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Blood factors or platelets should be administered to patients who have bleeding disorders that can be treated with such products. The remainder of the evaluation is undertaken after the patient is stabilized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important aspects of the history in a child with epistaxis include [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      How old is the child? Epistaxis is rare in children younger than two years (approximately 1 per 10,000) and should prompt consideration of trauma (intentional or unintentional) or serious illness (eg, thrombocytopenia) [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/6,7\">",
"       6,7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      When did the bleeding begin? Prolonged bleeding may be suggestive of a bleeding disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/8-10\">",
"       8-10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Is it bilateral or unilateral? Unilateral bleeding indicates that there may be an isolated lesion or minor trauma, whereas bilateral bleeding is more suggestive of general mucosal irritation, systemic etiology or major nasal trauma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link\">",
"       \"Epidemiology and etiology of epistaxis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      How much blood has been lost? Estimation of the quantity of blood loss is difficult; the quantity of bleeding in posterior epistaxis is often underestimated because much of the blood is swallowed [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Is there blood in the mouth or vomitus? Posterior bleeding is suggested by initial awareness of bleeding in the back of the throat",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      swallowed blood [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/4\">",
"       4",
"      </a>",
"      ]. Patients with swallowed blood may present with complaints of hematemesis or melena [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      What measures were taken to stop the bleeding? Bleeding that is difficult to control with anterior pressure may indicate a bleeding disorder or a posterior source of bleeding [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/2,3\">",
"       2,3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Is there a history of trauma (including nose picking)? Some providers find that asking children which finger they use to pick their nose elicits a more honest answer about nose picking [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/3\">",
"       3",
"      </a>",
"      ]. Nasal trauma (such as a broken nose) usually causes epistaxis that in most cases resolves spontaneously. Massive epistaxis after head trauma is rarely a sign of internal carotid pseudoaneurysm [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/11-13\">",
"       11-13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Is there a history of nasal congestion, discharge, or obstruction? Has there been an insertion of a foreign body? Ongoing nasal discharge, especially during the spring and fall implies possible allergic rhinitis. Nasal obstruction with mucopurulent drainage and facial pain, especially during the winter suggests chronic sinusitis. Progressively worsening nasal obstruction over the past several weeks implies possible nasal tumor. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22362?source=see_link\">",
"       \"Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=see_link\">",
"       \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Is there a recent history of nasal surgery? It is not uncommon to have epistaxis after an adenoidectomy or other nasal surgery; post-operative epistaxis usually is self-limiting but can require intervention by the otolaryngologist.",
"     </li>",
"     <li>",
"      Are there associated symptoms? Areas of ecchymosis may indicate a bleeding disorder. Headaches",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      facial pain may be related to an intracranial mass. Fever and hepatomegaly suggest the possibility of dengue hemorrhagic fever. Hearing loss and cranioneuropathies may suggest rhabdomyosarcoma. Hearing loss, torticollis, trismus, unilateral cervical adenopathy, retrobulbar or ear pain, and neck pain may suggest nasopharyngeal carcinoma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link\">",
"       \"Epidemiology and etiology of epistaxis in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Past medical history, family history, and review of systems should include information regarding:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Allergies",
"     </li>",
"     <li>",
"      Medications (particularly nasal corticosteroids,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/10/19624?source=see_link\">",
"       aspirin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=see_link\">",
"       ibuprofen",
"      </a>",
"      ), drugs of abuse (cocaine, heroin, inhalants) [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/5,14\">",
"       5,14",
"      </a>",
"      ], and",
"      <span class=\"nowrap\">",
"       complementary/alternative",
"      </span>",
"      therapies (ie, ginkgo biloba)",
"     </li>",
"     <li>",
"      Number, frequency, and seasonality of previous episodes. Intermittent epistaxis may be caused by changes in the weather, allergies, low humidification of inspired air; intermittent epistaxis also may be related to menses [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/2\">",
"       2",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      History of easy bruising or bleeding problems in the patient or family",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EXAMINATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of a child with epistaxis can be difficult. For some children, sedation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    analgesia may be beneficial. Examination of the nasopharynx may be facilitated by the application of a topical vasoconstricting",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anesthetic agent (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/57/37776?source=see_link\">",
"     lidocaine",
"    </a>",
"    alone or lidocaine mixed with a vasoconstricting agent, such as 0.025",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/22/35168?source=see_link\">",
"     oxymetazoline",
"    </a>",
"    hydrochloride) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. The vasoconstricting agent can be applied with a spray bottle or a cotton pledget (placed into the nose with forceps and removed after five minutes). The nasal cavity may be inspected before or during application of the vasoconstricting agent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/4,14\">",
"     4,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     General examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with epistaxis should undergo a complete general examination, with special attention to hemodynamic compromise and signs of systemic causes of bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The following aspects are particularly important:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vital signs, including blood pressure and heart rate [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/2\">",
"       2",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pallor (as an indication of decreased blood loss or anemia)",
"     </li>",
"     <li>",
"      Petechiae, bruising, gingival bleeding; hemotympanum may be present due to the reflux of blood into the eustachian tube [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/16\">",
"       16",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Examination of the oropharynx (for signs of posterior bleeding)",
"     </li>",
"     <li>",
"      Mucocutaneous telangiectasias, hemangiomas",
"     </li>",
"     <li>",
"      Enlarged lymph nodes, organomegaly, petechiae, pallor (as indications of hematologic disease or malignancy)",
"     </li>",
"     <li>",
"      Icterus as a sign of liver disease (with secondary coagulopathy)",
"     </li>",
"     <li>",
"      Visual acuity and extraocular movements should be tested in children with a history of facial trauma",
"     </li>",
"     <li>",
"      Orbit (blood can reflux up the nasolacrimal duct and appear in the medial canthus and along the lower eyelid)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Nasopharynx",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most nosebleeds in children are anterior, posterior bleeds are important to identify because they may require more extensive management [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. Specific sites to be examined include the nasal septum (Kiesselbach's plexus), the sphenopalatine artery area (behind the middle turbinate), the ethmoidal vessel area (superior nasal vault), and the nasopharynx (",
"    <a class=\"graphic graphic_figure graphicRef54180 \" href=\"UTD.htm?0/23/374\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Initial inspection may be accomplished by using one's thumb to push the tip of the nose upward. This permits examination of the vestibule, the anterior portion of the septum, and the anterior portion of the inferior turbinate [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/3\">",
"     3",
"    </a>",
"    ]. A more thorough inspection for anterior septal bleeding can be completed by anterior rhinoscopy using a headlight or head mirror and nasal speculum. Alternatively, an otoscope with a large tip may be used in the young child who has difficulty holding still. The area of Kiesselbach's plexus should be inspected first since it is the source of the majority of nosebleeds. This area should be examined for active bleeding, scabs, ulcerations, erosions, or prominent blood vessels.",
"   </p>",
"   <p>",
"    Failure to identify a source of anterior bleeding may indicate posterior bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/5\">",
"     5",
"    </a>",
"    ]. Examination for more posterior bleeding is usually performed by an otolaryngologist with flexible or rigid fiberoptic endoscopy.",
"   </p>",
"   <p>",
"    In addition to evaluation for a bleeding source, examination of the nose and nasopharynx should include inspection for other potential causes of bleeding including (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link\">",
"     \"Epidemiology and etiology of epistaxis in children\"",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Foreign bodies",
"     </li>",
"     <li>",
"      Mucosal",
"      <span class=\"nowrap\">",
"       inflammation/lesions",
"      </span>",
"     </li>",
"     <li>",
"      Masses (tumors)",
"     </li>",
"     <li>",
"      Rhinitis (infectious or allergic)",
"     </li>",
"     <li>",
"      Signs of allergy (pale or bluish nasal mucosa and edematous, boggy nasal turbinates)",
"     </li>",
"     <li>",
"      Vascular anomalies (telangiectasia, hemangioma)",
"     </li>",
"     <li>",
"      Juvenile angiofibromas (especially in teenage boys) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76702 \" href=\"UTD.htm?33/3/33842\">",
"       image 1",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory evaluation is not indicated in the majority of children with self-limited epistaxis. However, laboratory evaluation is indicated in children with recurrent, severe, or refractory epistaxis and those with historical or examination findings suggestive of a bleeding disorder or other systemic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/3\">",
"     3",
"    </a>",
"    ]. Epistaxis may be the sole manifestation of von Willebrand disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24794?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical presentation and diagnosis of von Willebrand disease\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Consultation with a hematologist before ordering labs can ensure that all of the necessary tests are performed, since sophisticated testing may be required to detect mild bleeding disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3722?source=see_link\">",
"     \"Approach to the child with bleeding symptoms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Laboratory evaluation for bleeding disorder may include (",
"    <a class=\"graphic graphic_table graphicRef67121 \" href=\"UTD.htm?36/13/37084\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef60745 \" href=\"UTD.htm?19/60/20430\">",
"     algorithm 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/2,3,8\">",
"     2,3,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blood type and",
"      <span class=\"nowrap\">",
"       screen/cross-match",
"      </span>",
"      for patients with severe bleeding who may require transfusion",
"     </li>",
"     <li>",
"      Complete blood count with platelet count and examination of the smear (",
"      <a class=\"graphic graphic_algorithm graphicRef82633 \" href=\"UTD.htm?16/40/17038\">",
"       algorithm 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Prothrombin time (PT)",
"     </li>",
"     <li>",
"      Activated partial thromboplastin time (PTT)",
"     </li>",
"     <li>",
"      Prothrombin time international normalized ratio (INR) if the child is receiving anticoagulation therapy",
"     </li>",
"     <li>",
"      Evaluation for von Willebrand disease, if clinically indicated (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24794?source=see_link\">",
"       \"Clinical presentation and diagnosis of von Willebrand disease\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     RADIOLOGIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contrast-enhanced computed tomography or magnetic resonance imaging should be performed in children with epistaxis if a mass is visualized or suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link\">",
"     \"Epidemiology and etiology of epistaxis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Consultation with a pediatric oncologist",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    otolaryngologist is warranted if neoplasm is suspected. Such consultation can ensure that the appropriate laboratory evaluation, radiographs, and histopathologic studies are obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18086/abstract/4,14\">",
"     4,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/50/1826?source=see_link\">",
"       \"Patient information: Nosebleeds (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/10/19617?source=see_link\">",
"       \"Patient information: Nosebleeds (epistaxis) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although nosebleeds are rarely life threatening, the initial evaluation should focus on the respiratory and hemodynamic stability of the patient. Rapid assessment of general appearance, vital signs, airway stability, and mental status are necessary to identify children with epistaxis who require airway intervention",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      fluid resuscitation. Identification of the source of bleeding and initiation of bleeding control measures follow immediately. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Emergency treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The history is directed toward determination of the etiology of bleeding. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link\">",
"       \"Epidemiology and etiology of epistaxis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Examination of a child with epistaxis can be difficult. For some children, sedation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      analgesia may be beneficial. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The general examination is directed toward findings related to systemic causes of bleeding. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'General examination'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link\">",
"       \"Epidemiology and etiology of epistaxis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The nasal and nasopharyngeal examination is directed toward findings related to localized causes of bleeding (mucosal abnormalities, foreign bodies, masses, anatomic abnormalities, vascular abnormalities). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Nasopharynx'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link\">",
"       \"Epidemiology and etiology of epistaxis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Routine laboratory evaluation is not indicated for most children with self-limited epistaxis. However, evaluation for bleeding disorder (complete blood count, with platelet count and examination of the peripheral smear, prothrombin time, and activated partial thromboplastin time) is indicated in patients with frequent recurrent nosebleeds, severe nosebleeds that are difficult to control, and those with personal or family history suggestive of a bleeding disorder. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Contrast-enhanced computed tomography or magnetic resonance imaging should be performed in children with epistaxis if a mass is visualized or suspected. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Radiologic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/1\">",
"      Brown NJ, Berkowitz RG. Epistaxis in healthy children requiring hospital admission. Int J Pediatr Otorhinolaryngol 2004; 68:1181.",
"     </a>",
"    </li>",
"    <li>",
"     Edelstein DR, Khabie N. Epistaxis. In: Primary Pediatric Care, 4th, Hoekelman RA (Ed), Mosby, St. Louis 2001. p.1058.",
"    </li>",
"    <li>",
"     Nadel F, Henretig FM. Epistaxis. In: Textbook of Pediatric Emergency Medicine, 5th, Fleisher GR, Ludwig S, Henretig FM.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.263.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/4\">",
"      Alvi A, Joyner-Triplett N. Acute epistaxis. How to spot the source and stop the flow. Postgrad Med 1996; 99:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/5\">",
"      Bernius M, Perlin D. Pediatric ear, nose, and throat emergencies. Pediatr Clin North Am 2006; 53:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/6\">",
"      McIntosh N, Mok JY, Margerison A. Epidemiology of oronasal hemorrhage in the first 2 years of life: implications for child protection. Pediatrics 2007; 120:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/7\">",
"      Hey E. Sudden oronasal bleeding in a young child. Acta Paediatr 2008; 97:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/8\">",
"      Sandoval C, Dong S, Visintainer P, et al. Clinical and laboratory features of 178 children with recurrent epistaxis. J Pediatr Hematol Oncol 2002; 24:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/9\">",
"      Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. J Pediatr 1998; 133:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/10\">",
"      Katsanis E, Luke KH, Hsu E, et al. Prevalence and significance of mild bleeding disorders in children with recurrent epistaxis. J Pediatr 1988; 113:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/11\">",
"      Coleman CC Jr. Diagnosis and treatment of congenital arteriovenous fistulas of the head and neck. Am J Surg 1973; 126:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/12\">",
"      Pathak PN. Epistaxis--due to ruptured aneurysm of the internal carotid artery. J Laryngol Otol 1972; 86:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/13\">",
"      K&ouml;roglu M, Arat A, Cekirge S, et al. Giant cervical internal carotid artery pseudoaneurysm in a child: endovascular treatment. Neuroradiology 2002; 44:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/14\">",
"      Guarisco JL, Graham HD 3rd. Epistaxis in children: causes, diagnosis, and treatment. Ear Nose Throat J 1989; 68:522, 528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/15\">",
"      Krempl GA, Noorily AD. Use of oxymetazoline in the management of epistaxis. Ann Otol Rhinol Laryngol 1995; 104:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18086/abstract/16\">",
"      Hurtado TR, Zeger WG. Hemotympanums secondary to spontaneous epistaxis in a 7-year-old. J Emerg Med 2004; 26:61.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6451 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-199.231.185.123-B6CE745EC8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18086=[""].join("\n");
var outline_f17_42_18086=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EMERGENCY TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      General examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Nasopharynx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      RADIOLOGIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6451\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6451|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?19/60/20430\" title=\"algorithm 1\">",
"      Algorithm for evaluating children for disorders of hemostasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?16/40/17038\" title=\"algorithm 2\">",
"      Mucocutaneous bleeding children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6451|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/3/33842\" title=\"diagnostic image 1\">",
"      Juvenile angiofibroma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6451|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/23/374\" title=\"figure 1\">",
"      Anatomy medial nasal wall",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6451|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/47/18172\" title=\"table 1\">",
"      Etiology epistaxis children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/13/37084\" title=\"table 2\">",
"      Test results bleeding disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22362?source=related_link\">",
"      Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3722?source=related_link\">",
"      Approach to the child with bleeding symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=related_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24794?source=related_link\">",
"      Clinical presentation and diagnosis of von Willebrand disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=related_link\">",
"      Emergent endotracheal intubation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=related_link\">",
"      Epidemiology and etiology of epistaxis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=related_link\">",
"      Hypovolemic shock in children: Initial evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26536?source=related_link\">",
"      Management of epistaxis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/50/1826?source=related_link\">",
"      Patient information: Nosebleeds (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/10/19617?source=related_link\">",
"      Patient information: Nosebleeds (epistaxis) (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_42_18087="Second degree atrioventricular block: Mobitz type I (Wenckebach block)";
var content_f17_42_18087=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Second degree atrioventricular block: Mobitz type I (Wenckebach block)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/42/18087/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18087/contributors\">",
"     William H Sauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/42/18087/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18087/contributors\">",
"     Leonard I Ganz, MD, FHRS, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/42/18087/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18087/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/42/18087/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrioventricular (AV) block is defined as a delay or interruption in the transmission of an impulse, either transient or permanent, from the atria to the ventricles due to an anatomic or functional impairment in the conduction system. The conduction can be delayed, intermittent, or absent. The commonly used terminology includes first degree AV block (slowed conduction without missed beats), second degree AV block (missed beats, often in a regular pattern, eg, 2:1, 3:2, or higher degrees of block), and third degree or complete AV block.",
"   </p>",
"   <p>",
"    In second degree AV block, some atrial impulses fail to reach the ventricles. Wenckebach described progressive delay between atrial and ventricular contraction and the eventual failure of an atrial beat to reach the ventricles [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/1\">",
"     1",
"    </a>",
"    ]. Mobitz subsequently divided second degree AV block into two subtypes, as determined by the findings on the electrocardiogram (ECG) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mobitz type I AV block, in which progressive PR interval prolongation precedes a non-conducted P wave.",
"     </li>",
"     <li>",
"      Mobitz type II AV block, in which the PR interval remains unchanged prior to a P wave that suddenly fails to conduct to the ventricles.",
"     </li>",
"     <li>",
"      Advanced second degree AV block, in which two or more consecutive P waves are non-conducted. In contrast to third degree or complete heart block, however, some P waves continue to be conducted to the ventricle.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Mobitz type I (Wenckebach) AV block will be reviewed here. Mobitz type II AV block and the etiology of AV block are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/62/998?source=see_link\">",
"     \"Second degree atrioventricular block: Mobitz type II\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32007?source=see_link\">",
"     \"Etiology of atrioventricular block\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     AV BLOCK: TYPE I VERSUS TYPE II",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with second degree AV block with a ratio of atrial to ventricular conduction that is not 2:1, the PR interval on the standard ECG can be used to distinguish Mobitz type I and Mobitz type II AV block:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In Mobitz type I AV block, there is progressive PR interval prolongation for several beats preceding the non-conducted P wave (",
"      <a class=\"graphic graphic_waveform graphicRef73051 \" href=\"UTD.htm?42/35/43573\">",
"       waveform 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In Mobitz type II AV block, the PR interval remains unchanged prior to a P wave that suddenly fails to conduct to the ventricles (",
"      <a class=\"graphic graphic_waveform graphicRef58649 \" href=\"UTD.htm?33/33/34328\">",
"       waveform 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The distinction between Mobitz type I and type II AV block cannot be made from the ECG when 2:1 AV block is present. In this situation, every other beat is non-conducted and there is no opportunity to observe for possible PR prolongation that is characteristic of Mobitz type I AV block. To aid in the diagnosis, a long rhythm strip should be obtained or a previous ECG examined to try to find evidence of PR prolongation with non-conducted beats in a pattern other than 2:1 (eg, 3:2, 4:3, etc).",
"   </p>",
"   <p>",
"    Certain ECG features may add in differentiating Mobitz type I from Mobitz type II AV block if a 2:1 block is present. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      If the PR interval of a conducted beat is very long (&gt;300 msec) or the QRS complex is narrow, the level of block is more likely to be in the AV node (type I).",
"     </li>",
"     <li>",
"      If",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"       atropine",
"      </a>",
"      is administered and there is enhanced AV nodal conduction resulting in less frequent non-conducted beats (ie, a 3:2 cycle), this confirms type I block.",
"     </li>",
"     <li>",
"      Carotid sinus massage would be expected to worsen Mobitz type I AV block by slowing AV nodal conduction. In Mobitz type II AV block, however, carotid sinus massage could paradoxically result in the elimination of infranodal block by slowing the sinus rate to allow for a longer time for infranodal repolarization.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two variations of Mobitz type I AV block which show Wenckebach periodicity: classic and atypical.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Classic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classic Mobitz type I AV block usually occurs within the AV node, but may also reflect a delay in the transmission of an impulse from the SA node to the atrium or a delay elsewhere in the conduction system. Classic Mobitz type I AV block can be observed in antegrade AV conduction, retrograde VA conduction across the AV node, or as part of exit block with ectopic and parasystolic pacemakers.",
"   </p>",
"   <p>",
"    Regardless of the site involved, what follows is a sequence in which there is a gradually increasing PR interval, usually a gradually decreasing R-R interval, and eventually a dropped beat (",
"    <a class=\"graphic graphic_waveform graphicRef73051 \" href=\"UTD.htm?42/35/43573\">",
"     waveform 1",
"    </a>",
"    ). The following factors are required for this sequence to occur:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A constant input &ndash; The constant input is the SA nodal pacemaker that gives rise to atrial depolarization.",
"     </li>",
"     <li>",
"      An area of increasing conduction delay and a dropped beat &ndash; The PR interval is shortest in the first beat in the cycle and increases with each ensuing beat. However, the largest",
"      <strong>",
"       absolute increase in delay",
"      </strong>",
"      occurs in the first beat, a lesser increase in delay occurs in the second beat, and so forth. The impulse eventually conducts very slowly and block occurs, resulting in a dropped beat (no associated QRS complex). If the pause between the last conducted beat and the first apparent beat of the next cycle is very long, the first beat may, in fact, be a junctional escape rather than a conducted beat. Almost invariably, the second beat of the new cycle will have a PR interval shorter than that of the last conducted beat that preceded the dropped beat.",
"     </li>",
"     <li>",
"      An output with a decreasing interval &ndash; The output, in this case the QRS-QRS interval (more commonly called the R-R interval), usually decreases with each beat of the cycle. The shortening R-R interval results from the decreasing increment in delay of AV nodal conduction (eg, the PR interval of beat 1 in a cycle increases by 0.05 seconds [from 0.18 to 0.23], the PR interval of next beat increases by 0.03 seconds [from 0.23 to 0.26], etc).",
"     </li>",
"     <li>",
"      Group beating &ndash; The classic Wenckebach pattern occurs usually with ratios of 3:2, 4:3 or 5:4. This gives rise to a clustering of beats with decreasing R-R intervals that tends to repeat. Not infrequently, mixed ratios occur. Conduction ratios of over 7:6 usually show the atypical pattern rather than the classic pattern.",
"     </li>",
"     <li>",
"      Pause shorter than two input cycles &ndash; The R-R interval involving the non-conducted beat is less than the summed R-R interval of any two previous cycles. This also results from the incremental conduction delay as the P wave that is not conducted is closer to the preceding QRS than any other in the cycle.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Atypical",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once conduction ratios exceed 6:5 or 7:6, the progressive increment in PR interval becomes unpredictable and the PR interval remains prolonged but constant. The most common explanation is that the sinus rate changes which, in turn, influences the PR interval through hemodynamic and autonomic effects. The PR interval is still longest in the beat before the dropped beat, shortest in the first beat of the cycle, and then increases in the second beat (",
"    <a class=\"graphic graphic_waveform graphicRef78766 \" href=\"UTD.htm?3/20/3399\">",
"     waveform 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Site of block",
"    </span>",
"    &nbsp;&mdash;&nbsp;The above discussion allows us to make some generalizations about the usefulness of clinical approaches to determining the site of the Mobitz type I AV block. The site of block is in the AV node in most cases (70 to 75 percent), with the remaining cases involving the His bundle, bundle branches, or fascicles [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Electrocardiogram &ndash; The ECG cannot pinpoint with certainty the site of the Mobitz type I AV block, although the classic pattern favors the AV node as the site of delay [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]. It is important to appreciate that the distinction between Mobitz type I and Mobitz type II AV block cannot be made from the ECG when 2:1 block is present. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'AV block: Type I versus type II'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      His bundle electrocardiogram &ndash; His bundle electrocardiography, as part of an invasive electrophysiologic (EP) study, can easily confirm the site of the Mobitz type I AV block. If the block is occurring in the AV node, the AH intervals will go through the same sequence described above for the PR interval. If, however, the block is occurring in the His bundle, there will usually be two His potentials (H and H') due to the slowing of conduction. In this setting, the H-H' interval will prolong before the H' and subsequent QRS complex are dropped.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ETIOLOGY AND CLINICAL IMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uncomplicated Mobitz type I AV block does not produce symptoms. However, if the sinus rate is slow and there are fewer conducted beats (2:1 or 3:2 block), there may be a significant reduction in cardiac output and symptoms of hypoperfusion (including fatigue, lightheadedness, syncope, presyncope, or angina) or heart failure.",
"   </p>",
"   <p>",
"    Mobitz type I AV block can occur in normal subjects, athletes, older adults, and in patients with certain heart diseases or who are taking drugs that block the AV node (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    , beta blockers, calcium channel blockers). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28072?source=see_link\">",
"     \"Basic approach to arrhythmias due to digoxin toxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mobitz type I and Mobitz type II AV block have different sites of involvement and different prognoses for progression to complete heart block.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mobitz type I AV block most often involves the AV node and rarely progresses to complete heart block.",
"     </li>",
"     <li>",
"      Mobitz type II AV block usually occurs below the AV node (in the infra-Hisian structures) and can progress to complete heart block.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Normal subjects and athletes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mobitz type I AV block can occur in individuals who have high vagal tone, such as younger persons or highly conditioned athletes at rest [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/6-12\">",
"     6-12",
"    </a>",
"    ]. The prognosis is excellent in these settings, as progressive block does not appear to occur [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/7,9-11\">",
"     7,9-11",
"    </a>",
"    ]. Progression to third degree (complete) heart block has been reported in infants (occurring in 7 of 16 in one study) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sinus bradycardia and AV conduction abnormalities are often observed in well-trained endurance athletes. As an example, Mobitz type I AV block has been described in 2 to 10 percent of long-distance runners [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/12\">",
"     12",
"    </a>",
"    ]. It has been suggested that these findings are related to increased parasympathetic activity because of their association with training and detraining and their disappearance after vagolytic or sympathetic maneuvers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/11\">",
"     11",
"    </a>",
"    ]. However, intrinsic AV nodal mechanisms may also be involved, as suggested from a study of well-trained endurance athletes [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/14\">",
"     14",
"    </a>",
"    ]. In the presence of both sympathetic and parasympathetic blockade of the heart, these athletes developed slow AV nodal conduction and a propensity to develop Wenckebach cycles.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Underlying heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mobitz type I AV block can occur in patients with intrinsic AV nodal disease, myocarditis (including Chagas disease), acute inferior myocardial infarction or ischemia (",
"    <a class=\"graphic graphic_waveform graphicRef62040 \" href=\"UTD.htm?6/7/6262\">",
"     waveform 4",
"    </a>",
"    ), and cardiac surgery. In the majority of patients (about 90 percent), the right coronary artery supplies blood to the AV node. Thus, Mobitz type I AV block (due to ischemia of the AV node) can occur as a complication of an inferior myocardial infarction.",
"   </p>",
"   <p>",
"    The finding of Mobitz type I AV block in a patient with an inferior myocardial infarction is associated with increased mortality, presumably due to larger infarct size. The infarct does not typically extend to the AV node due to collaterals from the left coronary system. If, however, there is substantial left coronary disease, then right coronary occlusion may lead to complete heart block. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4282?source=see_link\">",
"     \"Conduction abnormalities after myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mobitz type I AV block, typically transient, has been described in approximately 3 percent of patients after mitral valve surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/15\">",
"     15",
"    </a>",
"    ]. Among patients with congenital heart disease, Mobitz type I AV block occurs most frequently in repaired tetralogy of Fallot and less often after repair of ventricular septal defects.",
"   </p>",
"   <p>",
"    AV block, primarily Mobitz type I, can be induced by a Valsalva maneuver in patients with Chagas disease who do not have overt cardiac involvement. This may indicate early vagal dysfunction or involvement of the AV node [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8023112\">",
"    <span class=\"h1\">",
"     ELECTROPHYSIOLOGY STUDY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrophysiology study is not usually performed in patients with Mobitz type I AV block, but may be considered to determine if patients who have otherwise unexplained syncope or presyncope are candidates for a pacemaker. In such patients, the following findings are possible indications for pacemaker placement (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link&amp;anchor=H14#H14\">",
"     \"Indications for permanent cardiac pacing\", section on 'Role of EP study'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      AV block at intra- or infra-His levels as opposed to within the AV node",
"     </li>",
"     <li>",
"      Markedly prolonged conduction between the His bundle and the ventricle (HV interval &gt;100 msec)",
"     </li>",
"     <li>",
"      Pacing-induced AV block below the His bundle",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to initiating treatment for Mobitz type I AV block, reversible causes of slowed conduction such a myocardial ischemia, increased vagal tone, and medications should be excluded. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32007?source=see_link\">",
"     \"Etiology of atrioventricular block\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If no reversible causes are present, the decision to treat Mobitz type I AV block should be made based on the presence of symptoms. Asymptomatic patients with Mobitz type I AV block do not require any specific therapy. Treatment of AV block involves the avoidance of medications that impair AV conduction (when possible), and permanent pacemaker placement in selected patients. Detailed reviews of the indications for permanent pacemaker placement and of the modes of cardiac pacing are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link&amp;anchor=H10#H10\">",
"     \"Indications for permanent cardiac pacing\", section on 'Acquired AV block'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=see_link\">",
"     \"Modes of cardiac pacing: Nomenclature and selection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the emergent setting,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    may also be effective by reversing the decrease in AV nodal conduction induced by vagal tone. A favorable response to atropine also suggests that AV block is due to abnormal conduction in the AV node, since the more distal conducting system is not as sensitive to vagal activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Symptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with Mobitz type I AV block and",
"    <strong>",
"     symptomatic",
"    </strong>",
"    bradycardia that is not due to a reversible etiology, we recommend implantation of a permanent pacemaker. This approach in symptomatic patients is in agreement with the recommendations of both the 2007 European Society of Cardiology (ESC) guidelines and the 2008 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/Heart",
"    </span>",
"    Rhythm Society",
"    <span class=\"nowrap\">",
"     (ACC/AHA/HRS)",
"    </span>",
"    guidelines regarding device-based therapy for arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link&amp;anchor=H10#H10\">",
"     \"Indications for permanent cardiac pacing\", section on 'Acquired AV block'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Less commonly, Mobitz type I AV block with symptoms similar to pacemaker syndrome (ie, palpitations) can occur, and when present warrants consideration of pacemaker placement. This phenomenon is referred to as \"pseudopacemaker\" syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=see_link&amp;anchor=H28#H28\">",
"     \"Modes of cardiac pacing: Nomenclature and selection\", section on 'Pacemaker syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10101639\">",
"    <span class=\"h2\">",
"     Asymptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;For the majority of patients with Mobitz type I AV block and",
"    <strong>",
"     asymptomatic",
"    </strong>",
"    bradycardia, we suggest",
"    <strong>",
"     not",
"    </strong>",
"    implanting a permanent pacemaker. This is particularly true in younger patients and those patients in whom the AV block is felt to be supra-Hisian in nature (ie, within the AV node). These patients should have regularly follow up, including a surface ECG, every 6 to 12 months with questioning focused on the interval development of symptoms (eg, fatigue, dyspnea, presyncope, syncope) which could be attributable to the AV block.",
"   </p>",
"   <p>",
"    Most asymptomatic patients with Mobitz type I AV block do not require invasive electrophysiology (EP) study. However, in patients who have otherwise unexplained syncope or presyncope in whom AV block may be the etiology (and therefore potentially symptomatic AV block), an EP study may be considered. In asymptomatic patients who have undergone invasive EP study to determine the level of block within the AV node, the decision regarding a pacemaker is based on the level of block:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients whose AV block is identified as infranodal, implantation of a permanent pacemaker can be considered based on the potential mortality benefit in asymptomatic patients whose block is identified as infranodal as well as a greater likelihood of progressive AV block and morbidity in patients with infranodal block. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link&amp;anchor=H10#H10\">",
"       \"Indications for permanent cardiac pacing\", section on 'Acquired AV block'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients whose AV block is identified at the supra-His level (ie, within the AV node), we do not place a permanent pacemaker.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients with Mobitz type I AV block who remain asymptomatic, there has been disagreement among clinicians and professional societies regarding optimal management, with the ESC guidelines suggesting pacemaker placement and the",
"    <span class=\"nowrap\">",
"     ACC/AHA/HRS",
"    </span>",
"    guidelines recommending against pacemaker placement. There are no randomized trial data to guide this decision. Observational data, with many limitations, provides some support for the use of a permanent pacemaker in such patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among a cohort of 86 asymptomatic patients with Mobitz type I AV block seen at a single institution in England from 1968 to 1993 (mean age 69 years, 65 percent male), 39 (45 percent) received a pacemaker for prophylactic purposes [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/19\">",
"       19",
"      </a>",
"      ]. Despite the absence of symptoms, five-year survival was significantly higher among the group who received a pacemaker (87 versus 54 percent in the unpaced group). All mortality occurred in those greater than 45 years of age.",
"     </li>",
"     <li>",
"      Among a cohort of 299 patients with Mobitz type I AV block seen at a single Veterans Affairs Medical Center in the US from 1992 to 2010 (mean age 75 years, 99 percent male), the majority (175 patients) remained asymptomatic, while 124 patients (41 percent) received a pacemaker for symptomatic bradycardia or progression to higher grade AV block [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18087/abstract/20\">",
"       20",
"      </a>",
"      ]. During an average follow up of 3.3 years, 190 patients (64 percent) died. Despite having greater cardiac comorbidity (eg, heart failure, coronary heart disease reduced left ventricular ejection fraction), patients who received a pacemaker had a 46 percent reduction in total mortality compared to those without a pacemaker (hazard ratio 0.54, 95% CI 0.35-0.83). This study, however, was a single center study in an elderly, predominantly male population with a high mortality rate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Our authors and editors feel that these data are insufficient to recommend pacemaker placement in patients with Mobitz type I block at the supra-His level (ie, within the AV node) or which is not demonstrated to be infranodal by EP evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Pacing mode",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with Mobitz type I AV block and symptomatic bradycardia who require a pacemaker, we implant a dual chamber DDD pacemaker whenever possible in an effort to maintain physiologic AV synchrony (",
"    <a class=\"graphic graphic_figure graphicRef71370 \" href=\"UTD.htm?28/21/29023\">",
"     figure 1",
"    </a>",
"    ). Single chamber VVI pacemakers were most commonly used in the past, and are still used in the emergent setting for temporary pacing or in patients with atrial tachyarrhythmias. However, single chamber VVI pacemakers do not allow for normal AV synchrony, the loss of which is hemodynamically unfavorable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=see_link\">",
"     \"Modes of cardiac pacing: Nomenclature and selection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/46/8931?source=see_link\">",
"       \"Patient information: Bradycardia (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?43/26/44449?source=see_link\">",
"       \"Patient information: Heart block in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8022855\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atrioventricular (AV) block is defined as a delay or interruption in the transmission of an impulse from the atria to the ventricles due to an anatomic or functional impairment in the conduction system. In Mobitz type I AV block, there is progressive PR interval prolongation for several beats preceding the nonconducted P wave, whereas in Mobitz type II AV block, the PR interval remains unchanged prior to a P wave that suddenly fails to conduct to the ventricles. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The following ECG findings are seen in Mobitz type I AV block (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathophysiology'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A constant input &ndash; The constant input is the SA nodal pacemaker that gives rise to atrial depolarization.",
"     </li>",
"     <li>",
"      An area of increasing conduction delay and a dropped beat &ndash; The PR interval is shortest in the first beat in the cycle and increases with each ensuing beat. However, the largest",
"      <strong>",
"       absolute increase in delay",
"      </strong>",
"      occurs in the first beat, a lesser increase in delay occurs in the second beat, and so forth.",
"     </li>",
"     <li>",
"      An output with a decreasing interval &ndash; The output, in this case the R-R interval, usually decreases with each beat of the cycle. The shortening R-R interval results from the decreasing increment in delay of AV nodal conduction.",
"     </li>",
"     <li>",
"      Group beating &ndash; The classic Wenckebach pattern occurs usually with ratios of 3:2, 4:3, or 5:4. This gives rise to a clustering of beats with decreasing R-R intervals that tends to repeat.",
"     </li>",
"     <li>",
"      Pause shorter than two input cycles &ndash; The R-R interval involving the nonconducted beat is less than the summed R-R interval of any two previous cycles. This also results from the incremental conduction delay as the P wave that is not conducted is closer to the preceding QRS than any other in the cycle.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Uncomplicated Mobitz type I AV block does not produce symptoms. However, if the sinus rate is slow and there are fewer conducted beats (2:1 or 3:2 block), there may be a significant reduction in cardiac output and symptoms of hypoperfusion (including fatigue, lightheadedness, syncope, or angina) or heart failure. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Etiology and clinical implications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mobitz type I AV block (due to ischemia of the AV node) can occur as a complication of an inferior myocardial infarction. The finding of Mobitz type I AV block in a patient with an inferior myocardial infarction is associated with increased mortality, presumably due to larger infarct size. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Underlying heart disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prior to initiating treatment for Mobitz type I AV block, reversible causes of slowed conduction such as myocardial ischemia, increased vagal tone, and medications should be excluded. If no reversible causes are present, and the patient is asymptomatic, no specific therapy is required. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with Mobitz type I AV block and",
"      <strong>",
"       symptomatic",
"      </strong>",
"      bradycardia, we recommend implantation of a permanent pacemaker (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). We implant a dual chamber DDD pacemaker whenever possible in an effort to maintain physiologic AV synchrony. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Symptomatic patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For the majority of patients with Mobitz type I AV block and",
"      <strong>",
"       asymptomatic",
"      </strong>",
"      bradycardia, we suggest",
"      <strong>",
"       not",
"      </strong>",
"      implanting a permanent pacemaker (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). This is particularly true in younger patients and those patients in whom the AV block is felt to be supra-Hisian in nature (ie, within the AV node). Exceptions to this include patients whose AV block is identified as infranodal during invasive electrophysiology (EP) study (in whom progression to higher degrees of AV block is possible) and elderly patients (in whom there may be greater mortality associated with Mobitz type I AV block); in such patients a permanent pacemaker may be considered. When a permanent pacemaker is implanted, we implant a dual chamber DDD pacemaker whenever possible in an effort to maintain physiologic AV synchrony. (See",
"      <a class=\"local\" href=\"#H10101639\">",
"       'Asymptomatic patients'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/1\">",
"      Wenckebach KF. Zur Analyse der unregelm&auml;ssigen Pulses. Ztschr klin Med 1899; 36:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/2\">",
"      Mobitz W. &Uuml;ber die unvollst&auml;ndige St&ouml;rung der Erregungs&uuml;berleitung zwischen Vorhof und Kammer des menschlichen Herzens. Z Gesamte Exp Med 1924; 41:180.",
"     </a>",
"    </li>",
"    <li>",
"     Peuch P, Groileau R, Guimond C. Incidence of different types of A-V block and their localization by His bundle recordings. In: The Conduction System of the Heart, Wellens HJJ, Lie KI, Janse MJ (Eds), Stenfert, Leiden, 1976. p.467.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/4\">",
"      Friedman HS, Gomes JA, Haft JI. An analysis of Wenckebach periodicity. J Electrocardiol 1975; 8:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/5\">",
"      Denes P, Levy L, Pick A, Rosen KM. The incidence of typical and atypical A-V Wenckebach periodicity. Am Heart J 1975; 89:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/6\">",
"      JOHNSON RL, AVERILL KH, LAMB LE. Electrocardiographic findings in 67,375 asymptomatic subjects. VII. Atrioventricular block. Am J Cardiol 1960; 6:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/7\">",
"      Brodsky M, Wu D, Denes P, et al. Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol 1977; 39:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/8\">",
"      Dickinson DF, Scott O. Ambulatory electrocardiographic monitoring in 100 healthy teenage boys. Br Heart J 1984; 51:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/9\">",
"      Meytes I, Kaplinsky E, Yahini JH, et al. Wenckebach A-V block: a frequent feature following heavy physical training. Am Heart J 1975; 90:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/10\">",
"      Viitasalo MT, Kala R, Eisalo A. Ambulatory electrocardiographic recording in endurance athletes. Br Heart J 1982; 47:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/11\">",
"      Zeppilli P, Fenici R, Sassara M, et al. Wenckebach second-degree A-V block in top-ranking athletes: an old problem revisited. Am Heart J 1980; 100:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/12\">",
"      Zehender M, Meinertz T, Keul J, Just H. ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J 1990; 119:1378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/13\">",
"      Young D, Eisenberg R, Fish B, Fisher JD. Wenckebach atrioventricular block (Mobitz type I) in children and adolescents. Am J Cardiol 1977; 40:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/14\">",
"      Stein R, Medeiros CM, Rosito GA, et al. Intrinsic sinus and atrioventricular node electrophysiologic adaptations in endurance athletes. J Am Coll Cardiol 2002; 39:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/15\">",
"      Meimoun P, Zeghdi R, D'Attelis N, et al. Frequency, predictors, and consequences of atrioventricular block after mitral valve repair. Am J Cardiol 2002; 89:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/16\">",
"      Oliveira E, Ribeiro AL, Assis Silva F, et al. The Valsalva maneuver in Chagas disease patients without cardiopathy. Int J Cardiol 2002; 82:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/17\">",
"      Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117:e350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/18\">",
"      Vardas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace 2007; 9:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/19\">",
"      Shaw DB, Gowers JI, Kekwick CA, et al. Is Mobitz type I atrioventricular block benign in adults? Heart 2004; 90:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18087/abstract/20\">",
"      Coumbe AG, Naksuk N, Newell MC, et al. Long-term follow-up of older patients with Mobitz type I second degree atrioventricular block. Heart 2013; 99:334.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 909 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-89.32.226.102-9F539080E8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18087=[""].join("\n");
var outline_f17_42_18087=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8022855\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      AV BLOCK: TYPE I VERSUS TYPE II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Classic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Atypical",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Site of block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ETIOLOGY AND CLINICAL IMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Normal subjects and athletes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Underlying heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8023112\">",
"      ELECTROPHYSIOLOGY STUDY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Symptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10101639\">",
"      Asymptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Pacing mode",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8022855\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/909\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/909|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/21/29023\" title=\"figure 1\">",
"      Pacemaker algorithm AV block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/909|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/35/43573\" title=\"waveform 1\">",
"      ECG Mobitz type I AV block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?33/33/34328\" title=\"waveform 2\">",
"      Mobitz type II second degree atrioventricular block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?3/20/3399\" title=\"waveform 3\">",
"      ECG atypical Mobitz type I AV block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?6/7/6262\" title=\"waveform 4\">",
"      ECG Mobitz type I AV block and inferior MI",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28072?source=related_link\">",
"      Basic approach to arrhythmias due to digoxin toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4282?source=related_link\">",
"      Conduction abnormalities after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32007?source=related_link\">",
"      Etiology of atrioventricular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=related_link\">",
"      Indications for permanent cardiac pacing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=related_link\">",
"      Modes of cardiac pacing: Nomenclature and selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/46/8931?source=related_link\">",
"      Patient information: Bradycardia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?43/26/44449?source=related_link\">",
"      Patient information: Heart block in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/62/998?source=related_link\">",
"      Second degree atrioventricular block: Mobitz type II",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_42_18088="Tracheomalacia and tracheobronchomalacia in adults";
var content_f17_42_18088=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Tracheomalacia and tracheobronchomalacia in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/42/18088/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18088/contributors\">",
"     Armin Ernst, MD, FCCP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18088/contributors\">",
"     Kelly Carden, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18088/contributors\">",
"     Sidhu P Gangadharan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/42/18088/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18088/contributors\">",
"     Praveen N Mathur, MB, BS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/42/18088/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/42/18088/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/42/18088/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tracheomalacia (TM) refers to diffuse or segmental tracheal weakness [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/1\">",
"     1",
"    </a>",
"    ]. Tracheobronchomalacia (TBM) exists when the weakness extends into one or both mainstem bronchi. Both conditions result in exaggerated luminal narrowing during expiration and widening during inspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. The airway narrowing can be extensive.",
"   </p>",
"   <p>",
"    We refer to TM and TBM collectively as TM in this review, since the conditions manifest similarly and the terms are frequently used interchangeably in practice. We distinguish between the disorders only when necessary.",
"   </p>",
"   <p>",
"    The classification, epidemiology, histopathology, natural history, symptoms, diagnosis, and treatment of TM are reviewed here. Tracheomalacia in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several classification systems exist for TM:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      TM can be classified according to the appearance of the trachea. Patients who have anteroposterior tracheal narrowing are said to have crescent (ie, scabbard shape) TM, while patients who have lateral tracheal narrowing are said to have saber-sheath (ie, fissure shape) TM.",
"     </li>",
"     <li>",
"      TM can be classified according to its distribution, as either segmental or diffuse. This is particularly useful for guiding therapy.",
"     </li>",
"     <li>",
"      TM can be classified as congenital (ie, primary) or acquired (ie, secondary) (",
"      <a class=\"graphic graphic_table graphicRef73937 \" href=\"UTD.htm?30/14/30955\">",
"       table 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]. Acquired TM is more common than congenital TM in adults.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Congenital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most types of congenital TM manifest during childhood and are due to inherited diseases that weaken the trachea (eg, mucopolychondritis). Such disorders are discussed in separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is a type of congenital tracheomegaly that typically presents during adulthood: idiopathic giant trachea (IGT). It is a rare condition caused by atrophy of the longitudinal elastic fibers and thinning of the muscularis mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/8\">",
"     8",
"    </a>",
"    ]. IGT can also present as tracheobronchomegaly (Mounier-Kuhn syndrome) when the defect extends into the central bronchi. The peripheral airways maintain a normal diameter [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/9\">",
"     9",
"    </a>",
"    ]. Tracheobronchomegaly can be diagnosed when the diameter of the trachea, right mainstem bronchus, and left mainstem bronchus exceed 3.0, 2.4, and 2.3 cm, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/10\">",
"     10",
"    </a>",
"    ]. These measurements represent three standard deviations above the upper limit of normal in adults.",
"   </p>",
"   <p>",
"    The cause of tracheobronchomegaly is uncertain but may be familial, at least partially [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/11\">",
"     11",
"    </a>",
"    ]. Patients with tracheobronchomegaly mobilize their secretions poorly and, therefore, manifest chronic accumulation of secretions, recurrent infections, bronchiectasis, and pulmonary fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/8\">",
"     8",
"    </a>",
"    ]. Tracheal diverticuli may develop due to the increased global compliance of the tracheal wall and the development of redundant membranous tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Acquired",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are numerous causes of acquired TM in adults. Some of the more common causes are described in the table (",
"    <a class=\"graphic graphic_table graphicRef73937 \" href=\"UTD.htm?30/14/30955\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tracheostomy or endotracheal intubation can destroy tracheal cartilage at the stoma or inflatable cuff site, respectively, which weakens the tracheal wall [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/6\">",
"       6",
"      </a>",
"      ]. This type of TM is usually segmental, with a length of 3 cm or less. Possible risk factors include recurrent intubation, prolonged intubation, and concurrent high-dose steroid therapy. The mechanism is uncertain but may include pressure necrosis, impaired blood flow, recurrent infections, mucosal friction, or mucosal inflammation [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other types of tracheal cartilage injury can also cause TM. These include external chest trauma and surgery (eg, lung transplantation) [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/14-16\">",
"       14-16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chronic compression of the trachea can cause TM. This is most commonly due to a benign mediastinal goiter [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/17\">",
"       17",
"      </a>",
"      ]. However, it can also be due to malignancy, vascular compression, an abscess, a cyst, or another benign lesion.",
"     </li>",
"     <li>",
"      Relapsing polychondritis leads to the destruction of cartilage and is associated with TM [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/18\">",
"       18",
"      </a>",
"      ]. In one study, nearly 50 percent of patients with relapsing polychondritis who were evaluated for airway involvement exhibited some degree of TM.",
"     </li>",
"     <li>",
"      Recurrent infection might cause TM. Supporting this hypothesis, TM is common among adults who have chronic bronchitis or cystic fibrosis. In an observational study that included 40 adults with cystic fibrosis and 10 control subjects, TM was detected by computed tomography in 24 of the patients with cystic fibrosis (69 percent) and none of the controls [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A substantial proportion of patients with severe emphysema have TM, suggesting that chronic inflammation due to the inhalation of irritants (eg, cigarette smoke) may cause TM [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/20,21\">",
"       20,21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other conditions and agents that may cause airway inflammation have also been associated with TM. Examples include exposure to mustard gas [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/22\">",
"       22",
"      </a>",
"      ] and gastroesophageal reflux disease (GERD) [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of TM in adults is uncertain because reports have been based on selected populations instead of general populations. Older studies indicate that acquired TM is most common in men who are over 40 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/4,17,21,24,25\">",
"     4,17,21,24,25",
"    </a>",
"    ]. These studies are supported by a more recent study from Japan, in which 4283 patients with pulmonary disease underwent bronchoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/26\">",
"     26",
"    </a>",
"    ]. The airway caliber narrowed more than 50 percent in 542 patients (12.7 percent). Among these patients, more than 70 percent were aged 50 to 80 years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     HISTOPATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is little known about the histopathological changes associated with TM in adults. Autopsy studies have found anteroposterior narrowing of the lumen accompanied by atrophy of the longitudinal elastic fibers and fragmentation of the tracheal cartilage [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/21,24,26-29\">",
"     21,24,26-29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;TM is progressive in most patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/2,21,30,31\">",
"     2,21,30,31",
"    </a>",
"    ]. In a study of 17 patients with TM who underwent repeat bronchoscopy, worse airway narrowing was detected in 76 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/21\">",
"     21",
"    </a>",
"    ]. A larger study followed 94 patients with TM, TBM, or bronchomalacia for an average of 5.2 years [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/31\">",
"     31",
"    </a>",
"    ]. Among those who underwent repeat bronchoscopy, most patients had worse disease, some had stable disease, and none improved. Six of the nine patients with TM progressed to TBM, while all five patients with bronchomalacia progressed to TBM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;TM can be asymptomatic, especially if the airway narrowing is mild. However, symptoms or signs often develop as the severity of airway narrowing progresses, if the patient becomes stressed (eg, during an infection), or in certain clinical situations (eg, general anesthesia, progressive hypercapnic respiratory failure, liberation from mechanical ventilation) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The major symptoms and signs of TM in adults are dyspnea, cough, and sputum retention [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/2\">",
"     2",
"    </a>",
"    ]. Severe paroxysms of coughing may interrupt daily activities. Wheezing or stridor may also exist. An associated barking cough (likened to a barking seal) has been reported and some patients report episodic choking, recurrent pulmonary infections, or syncope associated with forced exhalation or cough [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/34-38\">",
"     34-38",
"    </a>",
"    ]. Maneuvers can sometimes elicit signs of TM, including forced expiration, cough, a Valsalva maneuver, and certain positions (eg, recumbency).",
"   </p>",
"   <p>",
"    These symptoms and signs are nonspecific and are often attributed to alternative diagnoses including emphysema, chronic bronchitis, cigarette smoking, or asthma. When TM coexists with one or more of these conditions, the symptoms may seem out of proportion to the severity of any condition alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic modalities that are used to evaluate suspected TM include bronchoscopy, computed tomography, pulmonary function testing, and chest radiography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchoscopic visualization of dynamic airway collapse is the diagnostic gold standard. TM is considered mild if the operator estimates that the lumen narrows to 50 percent of its initial size during expiration, moderate if it narrows to 25 percent of its initial size, and severe if the anterior and posterior walls touch (",
"    <a class=\"graphic graphic_picture graphicRef72199 \" href=\"UTD.htm?19/40/20097\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/31\">",
"     31",
"    </a>",
"    ]. Flexible bronchoscopy is preferred because the patient is able to breathe spontaneously and follow commands.",
"   </p>",
"   <p>",
"    Some studies used deep breathing, forced expiration, Valsalva maneuvers, cough, and other maneuvers to elicit airway collapse during bronchoscopy. However, the significance of airway collapse in response to such maneuvers is unknown because the degree of airway collapse and the amount of expiratory effort have never been correlated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) may be useful in the diagnosis of TM since it has an accuracy rate as high as 97 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/39-42\">",
"     39-42",
"    </a>",
"    ]. Criteria for diagnosing TM by CT are currently the same as those for diagnosing TM by bronchoscopy. TM is considered mild if the lumen narrows to 50 percent of its initial size during expiration, moderate if it narrows to 25 percent of its initial size, and severe if the anterior and posterior walls touch (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52229 \" href=\"UTD.htm?4/24/4480\">",
"     image 1",
"    </a>",
"    ). The airways are measured in cross-section on images obtained at end-expiration.",
"   </p>",
"   <p>",
"    Diagnostic assessment by CT requires additional study and refinement before CT surpasses bronchoscopy as the diagnostic gold standard. At least one observational study has found that CT can reliably predict TM, especially when the predictive measure is the degree to which the sagittal diameter decreases from end-inhalation to end-exhalation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/40\">",
"     40",
"    </a>",
"    ]. However, the current diagnostic criterion of greater than 50 percent luminal narrowing may not be the optimal diagnostic threshold, since it is met in up to 78 percent of control subjects during forced exhalation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/43\">",
"     43",
"    </a>",
"    ]. The findings from the latter study underscore the variability of the normal collapsibility of the trachea. More research is needed to define what threshold might be used during CT evaluation to accurately predict clinically significant collapse of the airway.",
"   </p>",
"   <p>",
"    Ultrafast multidetector CT scanners permit volumetric central airway imaging in only a few seconds. This allows true dynamic assessment of TM because the airway can be imaged during a forced exhalation or cough maneuver [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Pulmonary function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary function tests (PFTs) can provide data supportive of a diagnosis of TM, but they are not diagnostic. Spirometry usually demonstrates obstruction that is proportional to the severity of the TM [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/31,39\">",
"     31,39",
"    </a>",
"    ]. The flow-volume loop is characterized by a low peak expiratory flow rate followed by a rapid decrease of flow (",
"    <a class=\"graphic graphic_figure graphicRef77738 \" href=\"UTD.htm?18/14/18669\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Alternating decelerations and accelerations of flow (ie, flow oscillations) may be seen on the expiratory curve of the flow-volume loop. In a retrospective review of 2,800 flow-volume loops, flow oscillations were identified in 40 patients (1.4 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/45\">",
"     45",
"    </a>",
"    ]. Physiological upper airway obstruction was detected in 14 of these patients (35 percent). These oscillations can be caused by TM, redundant pharyngeal tissue, neuromuscular disease, or structural or functional disorders of the larynx [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Chest radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway narrowing or dilation due to TM is a dynamic process, occurring at certain points during the respiratory cycle. Thus, routine anteroposterior and lateral chest radiographs often do not show an abnormality. When TM is caused by compression from other structures (eg, mediastinal goiter), however, the underlying abnormality may be detectable on plain radiographs [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Diagnostic approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;TM may be suspected on the basis of a patient's symptoms and signs. Alternatively, it may be suspected on the basis of pulmonary function test results or a chest radiograph that was performed for evaluation of the related symptoms and signs.",
"   </p>",
"   <p>",
"    Once TM is suspected, the patient should undergo both CT and bronchoscopy with forced exhalation maneuvers to evaluate the degree of TM. Both tests are necessary because either test alone may underestimate the degree of TM. As an example, sedation for bronchoscopy may prevent maximal effort during a forced exhalation maneuver, thereby underestimating the severity of the TM. If the forced exhalation maneuver is repeated during a CT scan when the patient is not sedated, the collapsibility of the airway may be more accurately determined. The converse may also occur.",
"   </p>",
"   <p>",
"    CT and bronchoscopy have unique advantages. CT is better able to show the distal extent of the TM when it extends into the segmental and subsegmental bronchi. This has implications for treatment, since neither stenting nor surgical options can correct the distal disease. Bronchoscopy provides information about the ease of navigation into and within the airways, which is useful for planning future interventions.",
"   </p>",
"   <p>",
"    The severity of TM is determined as described above. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Bronchoscopy'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H12\">",
"     'Computed tomography'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our approach to the management of TM is shown in the algorithm (",
"    <a class=\"graphic graphic_algorithm graphicRef57344 \" href=\"UTD.htm?19/38/20078\">",
"     algorithm 1",
"    </a>",
"    ). We begin by determining whether a patient with TM is symptomatic. Asymptomatic patients generally do not require therapy, whereas therapy is warranted for patients who are symptomatic.",
"   </p>",
"   <p>",
"    Initial treatment of symptomatic patients targets the underlying cause of the TM and coexisting conditions. As an example, patients whose TM is associated with tracheal stenosis due to prolonged intubation may be completely cured by surgical repair (eg, resection and reconstruction). Patients with coexisting chronic obstructive pulmonary disease (COPD) can improve if their medical regimen is optimized because the large COPD-related pressure swings in the thorax that increase fluctuations in the caliber of the abnormal tracheal segments, will be diminished.",
"   </p>",
"   <p>",
"    Following optimization of all coexisting conditions, a functional assessment is performed (eg, PFTs, six-minute walk test, quality of life assessment) in patients who remain symptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/1\">",
"     1",
"    </a>",
"    ]. The purpose of this assessment is to establish a baseline from which the response to therapy can be objectively measured.",
"   </p>",
"   <p>",
"    We insert silicone stents next, as a means of identifying patients who are most likely to benefit from central airway stabilization.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who are not surgical candidates, but who objectively improve following stent insertion, are managed with long-term stenting.",
"     </li>",
"     <li>",
"      Patients who are surgical candidates and objectively improve following stent insertion are evaluated for definitive surgical repair of the trachea.",
"     </li>",
"     <li>",
"      Patients who do not improve with stenting have the stents removed and no further intervention is offered unless their symptoms become extreme. In this situation, positive pressure therapy may be beneficial.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In is important to emphasize that improvement or lack of improvement following the insertion of the silicone stents needs to be objectively demonstrated and documented before the long-term intervention is chosen and implemented.",
"   </p>",
"   <p>",
"    An exception to this approach exists when the primary symptom of the TM is not dyspnea. Examples include patients whose primary symptom is paroxysmal cough or recurrent infection. In such cases, a stent trial probably will not yield improvement and the decision regarding surgery must be made on the basis of abnormal anatomy alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Stenting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Relief of focal airway obstruction via stenting often provides immediate improvement of both airflow and symptoms according to several case series and observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/14-16,48-50\">",
"     14-16,48-50",
"    </a>",
"    ], although these findings have not been universal [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Silicone stents are preferred for the management of TM. Although their insertion requires rigid bronchoscopy and general anesthesia, they are easily repositioned and removed. Their major disadvantage is that silicone stents often migrate, which generally manifests as a new cough. Stent migration requires repositioning, removal, or replacement of the stent under direct visualization. In our experience, silicone Y-shaped stents are less likely to migrate than tubular silicon stents. However, other stent-related complications (eg, infection, cough, mucus-plugging) occur with similar frequency [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Metal stents have been used to manage many types of airway obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. Metal stents have some advantages, including easy placement by flexible bronchoscopy, dynamic expansion, and preservation of mucociliary function with some stent types. However, they are not recommended for use in benign airway obstruction and are a poor choice for the treatment of TM because they cannot be easily removed and are associated with numerous complications [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Potential complications include the formation of granulation tissue and breakage [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/2\">",
"     2",
"    </a>",
"    ]. The latter can cause severe problems including airway obstruction and perforation (",
"    <a class=\"graphic graphic_picture graphicRef73938 \" href=\"UTD.htm?10/60/11200\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Surgical repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several surgical treatments for TM have been described, primarily in case series [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/27,56-62\">",
"     27,56-62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tracheobronchoplasty refers to surgical splinting of the posterior wall of the trachea with polypropylene mesh [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/62\">",
"       62",
"      </a>",
"      ]. It is the definitive operative treatment for TM. A right posterolateral thoracotomy is used to approach both the thoracic trachea and bilateral bronchi. Polypropylene mesh is sutured to the posterior membranous wall and anchored to the cartilaginous edges of the trachea and bronchi. The sutures are placed in partial-thickness fashion, resulting in a posterior splint that is entirely external to the airway lumen. This splint reconstitutes a C-shape to the tracheal cartilage and prevents the posterior membrane from intruding into the lumen (",
"      <a class=\"graphic graphic_picture graphicRef53691 \" href=\"UTD.htm?31/15/31989\">",
"       picture 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef62393 \" href=\"UTD.htm?43/28/44495\">",
"       image 2",
"      </a>",
"      ). A prospective cohort study that followed 35 patients with severe symptomatic tracheomalacia for three months following tracheobronchoplasty found that quality of life, dyspnea, mean exercise capacity, and functional status significantly improved following the procedure, compared to baseline [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Conventional resection and reconstruction is utilized in cases of focal malacia, most commonly in the cervical trachea. It has a low morbidity and mortality in experienced hands and provides curative relief without the need for multiple endoscopic interventions. However, like any resection of the trachea, it can have the unintended consequence of renarrowing the trachea (ie, tracheal stenosis).",
"     </li>",
"     <li>",
"      Tracheal replacement refers to replacement of the defective trachea with a new trachea made out of foreign material, donor tissue, nonviable tissue, autogenous tissue, or engineered tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/63,64\">",
"       63,64",
"      </a>",
"      ]. It has been considered for decades, but a reliable tracheal replacement has not been developed [",
"      <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Tracheostomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tracheostomy alone may be effective if the tracheostomy tube bypasses the abnormal tracheal segment or splints the abnormal airway open. Longer segments of TM may require longer tracheostomy tubes. Even if the TM is diffuse, tracheostomy may be beneficial as a route to deliver positive airway pressure.",
"   </p>",
"   <p>",
"    A tracheal T-tube is a type of stent. It has a narrow tube that connects at a right angle to a larger tube, forming the shape of the letter T. The narrow tube passes from the tracheal lumen through a cervical stoma, similar to a standard tracheostomy tube. The larger tube functions like a straight stent, spanning the cervical trachea. The inferior aspect of the larger tube can extend into the thoracic trachea. The airflow during breathing is through the lumen of the larger tube and the larynx if the narrow tube is capped externally. In contrast, the airflow is through both the narrow tube and the larynx if the narrow tube is uncapped. Occasionally, a silicone tracheal T-tube is used for long-term stenting, especially if the malacic segment is in the cervical or upper thoracic trachea.",
"   </p>",
"   <p>",
"    Tracheostomy itself can worsen TM by destroying the tracheal cartilage and weakening the tracheal wall. This is why tracheostomy is a treatment of last resort.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Positive pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continuous positive airway pressure (CPAP) can maintain an open airway and facilitate secretion drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/13,66\">",
"     13,66",
"    </a>",
"    ]. This is often initiated in the hospital during an acute illness. The patient initially receives continuous CPAP and is gradually transitioned to intermittent CPAP as tolerated.",
"   </p>",
"   <p>",
"    Patients may use intermittent CPAP as long-term therapy. However, CPAP does not appear to have a long-term impact on dyspnea or cough [",
"    <a class=\"abstract\" href=\"UTD.htm?17/42/18088/abstract/13,66\">",
"     13,66",
"    </a>",
"    ]. Positive airway pressure other than CPAP (eg, bilevel positive airway pressure) may be used instead if hypercapnic respiratory failure exists.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tracheomalacia (TM) refers to diffuse or segmental tracheal weakness. Tracheobronchomalacia (TBM) exists when the weakness extends into one or both mainstem bronchi. Both conditions result in exaggerated luminal narrowing during expiration and widening during inspiration. TM and TBM manifest similarly and the terms are often used interchangeably. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      TM can be asymptomatic, especially if the airway narrowing is mild. However, symptoms and signs frequently develop as the severity of airway narrowing progresses, if the patient becomes stressed, or in certain clinical situations. The major symptoms and signs of TM in adults are dyspnea, cough, sputum retention, and expiratory wheezing or stridor. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Computed tomography (CT) and bronchoscopy with forced exhalation maneuvers should both be performed when TM is suspected. Criteria for the diagnosis of TM are currently the same, regardless of which test is used to measure luminal narrowing. TM is considered mild if the lumen narrows to 50 percent of its initial size during expiration, moderate if it narrows to 25 percent of its initial size, and severe if the anterior and posterior walls touch. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Therapy is warranted in symptomatic patients with severe TM, but not asymptomatic patients. Initial treatment targets the underlying cause of the TM and all coexisting conditions that may be contributing to the symptoms. Patients who remain symptomatic after initial therapy should undergo a functional assessment (eg, pulmonary function tests, six-minute walk test). This functional assessment provides a baseline from which treatment response can be measured. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who remain symptomatic after initial therapy, we suggest silicone stenting as the next therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients who improve following silicone stent insertion, but are not surgical candidates, we suggest long-term stenting (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Stenting'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who improve following silicone stent insertion and are surgical candidates, we suggest evaluation for definitive surgical correction (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Tracheobronchoplasty is the definitive operative technique for most patients. This should take place in medical centers with specific expertise in this procedure. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Surgical repair'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who do not improve after silicone stent insertion, we suggest that the stents be removed (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). No further intervention needs to be offered unless their symptoms become extreme. In this situation, positive pressure therapy or a T-tube may be beneficial. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Tracheostomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Positive pressure'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/1\">",
"      Carden KA, Boiselle PM, Waltz DA, Ernst A. Tracheomalacia and tracheobronchomalacia in children and adults: an in-depth review. Chest 2005; 127:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/2\">",
"      Nuutinen J. Acquired tracheobronchomalacia. Eur J Respir Dis 1982; 63:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/3\">",
"      Austin J, Ali T. Tracheomalacia and bronchomalacia in children: pathophysiology, assessment, treatment and anaesthesia management. Paediatr Anaesth 2003; 13:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/4\">",
"      Filler RM, Rossello PJ, Lebowitz RL. Life-threatening anoxic spells caused by tracheal compression after repair of esophageal atresia: correction by surgery. J Pediatr Surg 1976; 11:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/5\">",
"      Kiely, EM, Spitz, L, Brereton, R. Management of tracheomalacia by aortopexy. Pediatr Surg Int 1987; 2:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/6\">",
"      Feist JH, Johnson TH, Wilson RJ. Acquired tracheomalacia: etiology and differential diagnosis. Chest 1975; 68:340.",
"     </a>",
"    </li>",
"    <li>",
"     Funatsu T, Taki T, Matsubara Y, et al. Diagnosis and treatment of tracheobronchomalaica with asthmatic attack. In: Bronchology: Research, Diagnostic and Therapeutic Aspects, Nakhosteen J, Maassen W (Eds), Nijhoff, The Hague 1981. p.237.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/8\">",
"      Schwartz M, Rossoff L. Tracheobronchomegaly. Chest 1994; 106:1589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/9\">",
"      Gay S, Dee P. Tracheobronchomegaly--the Mounier-Kuhn syndrome. Br J Radiol 1984; 57:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/10\">",
"      KATZ I, LEVINE M, HERMAN P. Tracheobronchiomegaly. The Mounier-Kuhn syndrome. Am J Roentgenol Radium Ther Nucl Med 1962; 88:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/11\">",
"      KIRKLIN JW, CLAGETT OT. Vascular \"rings\" producing respiratory obstruction in infants. Proc Staff Meet Mayo Clin 1950; 25:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/12\">",
"      Shin MS, Jackson RM, Ho KJ. Tracheobronchomegaly (Mounier-Kuhn syndrome): CT diagnosis. AJR Am J Roentgenol 1988; 150:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/13\">",
"      Ferguson GT, Benoist J. Nasal continuous positive airway pressure in the treatment of tracheobronchomalacia. Am Rev Respir Dis 1993; 147:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/14\">",
"      Susanto I, Peters JI, Levine SM, et al. Use of balloon-expandable metallic stents in the management of bronchial stenosis and bronchomalacia after lung transplantation. Chest 1998; 114:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/15\">",
"      Gotway MB, Golden JA, LaBerge JM, et al. Benign tracheobronchial stenoses: changes in short-term and long-term pulmonary function testing after expandable metallic stent placement. J Comput Assist Tomogr 2002; 26:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/16\">",
"      Bolot G, Poupart M, Pignat JC, et al. Self-expanding metal stents for the management of bronchial stenosis and bronchomalacia after lung transplantation. Laryngoscope 1998; 108:1230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/17\">",
"      Abdel Rahim AA, Ahmed ME, Hassan MA. Respiratory complications after thyroidectomy and the need for tracheostomy in patients with a large goitre. Br J Surg 1999; 86:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/18\">",
"      Ernst A, Rafeq S, Boiselle P, et al. Relapsing polychondritis and airway involvement. Chest 2009; 135:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/19\">",
"      McDermott S, Barry SC, Judge EE, et al. Tracheomalacia in adults with cystic fibrosis: determination of prevalence and severity with dynamic cine CT. Radiology 2009; 252:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/20\">",
"      Jokinen K, Palva T, Nuutinen J. Chronic bronchitis. A bronchologic evaluation. ORL J Otorhinolaryngol Relat Spec 1976; 38:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/21\">",
"      Jokinen K, Palva T, Sutinen S, Nuutinen J. Acquired tracheobronchomalacia. Ann Clin Res 1977; 9:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/22\">",
"      Ghanei M, Akbari Moqadam F, Mohammad MM, Aslani J. Tracheobronchomalacia and air trapping after mustard gas exposure. Am J Respir Crit Care Med 2006; 173:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/23\">",
"      Bibi H, Khvolis E, Shoseyov D, et al. The prevalence of gastroesophageal reflux in children with tracheomalacia and laryngomalacia. Chest 2001; 119:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/24\">",
"      HERZOG H. [Expiratory stenosis of the trachea &amp; great bronchi by loosening of the membraneous portion; plastic chip repair]. Thoraxchirurgie 1958; 5:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/25\">",
"      Nuutinen J, Leinonen A. Acquired tracheobronchomalacia. A cineradiographic study with bronchologicl correlations. Ann Clin Res 1977; 9:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/26\">",
"      Ikeda S, Hanawa T, Konishi T, et al. [Diagnosis, incidence, clinicopathology and surgical treatment of acquired tracheobronchomalacia]. Nihon Kyobu Shikkan Gakkai Zasshi 1992; 30:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/27\">",
"      POHL R. [Generalized malacia of the tracheobronchial tree (malacic tracheobronchopathy)]. Fortschr Geb Rontgenstr 1951; 74:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/28\">",
"      Campbell AH, Faulks LW. Expiratory air-flow pattern in tracheobronchial collapse. Am Rev Respir Dis 1965; 92:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/29\">",
"      KIENER M, KOBLET H, WYSS F. [Pathology of stenosed bronchial collapse with pulmonary emphysema]. Schweiz Med Wochenschr 1957; 87:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/30\">",
"      Greene R, Lechner GL. \"Saber-Sheath\" Trachea: A Clinical and Functional Study of Marked Coronal Narrowing of the Intrathoracic Trachea. Radiology 1975; 115:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/31\">",
"      Nuutinen J. Acquired tracheobronchomalacia. A clinical study with bronchological correlations. Ann Clin Res 1977; 9:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/32\">",
"      Katoh H, Saitoh S, Takiguchi M, et al. A case of tracheomalacia during isoflurane anesthesia. Anesth Analg 1995; 80:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/33\">",
"      Collard P, Freitag L, Reynaert MS, et al. Respiratory failure due to tracheobronchomalacia. Thorax 1996; 51:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/34\">",
"      Nuutinen J. Acquired tracheobronchomalacia. A bronchological follow-up study. Ann Clin Res 1977; 9:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/35\">",
"      Johnson TH, Mikita JJ, Wilson RJ, Feist JH. Acquired tracheomalacia. Radiology 1973; 109:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/36\">",
"      Imaizumi H, Kaneko M, Mori K, et al. Reversible acquired tracheobronchomalacia of a combined crescent type and saber-sheath type. J Emerg Med 1995; 13:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/37\">",
"      Demajumdar R, Rajesh PB. Have we got the full picture? J Laryngol Otol 1998; 112:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/38\">",
"      Koziej M, G&oacute;recka D. [Cough-syncope syndrome in tracheobronchomalacia]. Pneumonol Alergol Pol 1992; 60:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/39\">",
"      Gilkeson RC, Ciancibello LM, Hejal RB, et al. Tracheobronchomalacia: dynamic airway evaluation with multidetector CT. AJR Am J Roentgenol 2001; 176:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/40\">",
"      Aquino SL, Shepard JA, Ginns LC, et al. Acquired tracheomalacia: detection by expiratory CT scan. J Comput Assist Tomogr 2001; 25:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/41\">",
"      Stern EJ, Graham CM, Webb WR, Gamsu G. Normal trachea during forced expiration: dynamic CT measurements. Radiology 1993; 187:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/42\">",
"      Lee KS, Sun MR, Ernst A, et al. Comparison of Dynamic Expiratory CT With Bronchoscopy for Diagnosing Airway Malacia: A Pilot Evaluation. Chest 2007; 131:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/43\">",
"      Boiselle PM, O'Donnell CR, Bankier AA, et al. Tracheal collapsibility in healthy volunteers during forced expiration: assessment with multidetector CT. Radiology 2009; 252:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/44\">",
"      Boiselle PM, Feller-Kopman D, Ashiku S, et al. Tracheobronchomalacia: evolving role of dynamic multislice helical CT. Radiol Clin North Am 2003; 41:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/45\">",
"      Vincken W, Cosio MG. Flow oscillations on the flow-volume loop: a nonspecific indicator of upper airway dysfunction. Bull Eur Physiopathol Respir 1985; 21:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/46\">",
"      Garcia-Pachon E. Tracheobronchomalacia: a cause of flow oscillations on the flow-volume loop. Chest 2000; 118:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/47\">",
"      Vincken WG, Cosio MG. Flow oscillations on the flow-volume loop: clinical and physiological implications. Eur Respir J 1989; 2:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/48\">",
"      Dasgupta A, Dolmatch BL, Abi-Saleh WJ, et al. Self-expandable metallic airway stent insertion employing flexible bronchoscopy: preliminary results. Chest 1998; 114:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/49\">",
"      Ernst A, Majid A, Feller-Kopman D, et al. Airway stabilization with silicone stents for treating adult tracheobronchomalacia: a prospective observational study. Chest 2007; 132:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/50\">",
"      Murgu SD, Colt HG. Complications of silicone stent insertion in patients with expiratory central airway collapse. Ann Thorac Surg 2007; 84:1870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/51\">",
"      O'Donnell, CR, Feller-Kopman, D, Ernst A, et al. Pressure-flow relationships and airway dynamics in tracheobronchial malacia. Am J Respir Crit Care Med 2003; 167:A576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/52\">",
"      de Souza AC, Keal R, Hudson NM, et al. Use of expandable wire stents for malignant airway obstruction. Ann Thorac Surg 1994; 57:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/53\">",
"      George PJ, Irving JD, Khaghani A, Dick R. Role of the Gianturco expandable metal stent in the management of tracheobronchial obstruction. Cardiovasc Intervent Radiol 1992; 15:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/54\">",
"      Nesbitt JC, Carrasco H. Expandable stents. Chest Surg Clin N Am 1996; 6:305.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062115.htm (Accessed on August 25, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/56\">",
"      HERZOG H. [Relaxation and expiratory invagination of the membranous portion of the intrathoracic trachea and the main bronchi as cause of asphyxial attacks in bronchial asthma and the chronic asthmoid bronchitis of pulmonary emphysema]. Schweiz Med Wochenschr 1954; 84:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/57\">",
"      NISSEN R. [Preservation of the antrum instead of total gastrectomy in surgery of high-seated carcinoma of the stomach]. Schweiz Med Wochenschr 1954; 84:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/58\">",
"      Herzog H, Keller R, Allg&ouml;wer M. Special methods of diagnosing and treating obstructive diseases of the central airways. Chest 1971; 60:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/59\">",
"      Halttunen P. EDH-adhesive plastic support in the surgical treatment of tracheobronchial collapse. An experimental study and a report on clinical cases. Acta Chir Scand Suppl 1973; 440:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/60\">",
"      Amedee RG, Mann WJ, Lyons GD. Tracheomalacia repair using ceramic rings. Otolaryngol Head Neck Surg 1992; 106:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/61\">",
"      Majid A, Guerrero J, Gangadharan S, et al. Tracheobronchoplasty for severe tracheobronchomalacia: a prospective outcome analysis. Chest 2008; 134:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/62\">",
"      Lagisetty KH, Gangadharan SP. Tracheobronchoplasty for the treatment of tracheobronchomalacia. J Thorac Cardiovasc Surg 2012; 144:S58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/63\">",
"      Makris D, Holder-Espinasse M, Wurtz A, et al. Tracheal replacement with cryopreserved allogenic aorta. Chest 2010; 137:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/64\">",
"      Wurtz A, Porte H, Conti M, et al. Tracheal replacement with aortic allografts. N Engl J Med 2006; 355:1938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/65\">",
"      Grillo HC. Tracheal replacement: a critical review. Ann Thorac Surg 2002; 73:1995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/42/18088/abstract/66\">",
"      Adliff M, Ngato D, Keshavjee S, et al. Treatment of diffuse tracheomalacia secondary to relapsing polychondritis with continuous positive airway pressure. Chest 1997; 112:1701.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4406 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-189.41.181.191-2D925142A9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18088=[""].join("\n");
var outline_f17_42_18088=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Congenital",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Acquired",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      HISTOPATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Pulmonary function tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Chest radiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Diagnostic approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Stenting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Surgical repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Tracheostomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Positive pressure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4406\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4406|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?19/38/20078\" title=\"algorithm 1\">",
"      Rx algorithm tracheomalacia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4406|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/24/4480\" title=\"diagnostic image 1\">",
"      Tracheomalacia by CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/28/44495\" title=\"diagnostic image 2\">",
"      Tracheoplast tracheomalacia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4406|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/14/18669\" title=\"figure 1\">",
"      Tracheomalacia FV loop",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4406|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/40/20097\" title=\"picture 1\">",
"      Tracheomalacia bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/60/11200\" title=\"picture 2\">",
"      Fractured metallic stent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/15/31989\" title=\"picture 3\">",
"      Tracheoplasty surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4406|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/14/30955\" title=\"table 1\">",
"      Classification tracheomalacia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=related_link\">",
"      Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_42_18089="Telangiectatic osteosarcoma";
var content_f17_42_18089=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F87014&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F87014&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Telangiectatic osteosarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histologic appearance of a telangiectatic osteosarcoma with typical blood-filled cyst-like structures (yellow thick arrows) surrounded by malignant osteoblastic cells and malignant osteoblastic giant cells (white thin arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of M John Hicks, DDS, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18089=[""].join("\n");
var outline_f17_42_18089=null;
var title_f17_42_18090="Advanced case 10 with answer";
var content_f17_42_18090=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51306&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51306&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    Chronic obstructive pulmonary disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram showing characteristic signs of severe COPD including sinus tachycardia (107 beats/min), peaked P waves in leads II, III, aVF, and V1 (P pulmonale), right axis deviation, and delayed precordial transition zone in which the net QRS area does not become positive until lead V5. Nonspecific ST-T abnormalities are also present. Although not seen here, patients with COPD often have low voltage in the limb leads.The prominent S wave in V3 raises consideration of left ventricular hypertrophy (eg, to to concomitant systemic hypertension).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18090=[""].join("\n");
var outline_f17_42_18090=null;
var title_f17_42_18091="Sources dietary fat";
var content_f17_42_18091=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F80214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F80214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sources of dietary fat",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type of fat",
"       </td>",
"       <td class=\"subtitle1\">",
"        Food sources",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monounsaturated fatty acids",
"       </td>",
"       <td>",
"        Vegetable oils (canola, olive, sunflower, safflower), peanut, tree nuts, seeds, avocado",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polyunsaturated fatty acids; n-3 or omega-3",
"       </td>",
"       <td>",
"        <p>",
"         ALA - Vegetable oils (canola, soybean, walnut), flax/linseed/hemp seed, wheat germ; also vegetables of the cabbage family and some fortified eggs",
"        </p>",
"        <p>",
"         EPA and DHA - seafood (especially fatty fish); some infant formulas and fortified eggs",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polyunsaturated fatty acids; n-6 or omega-6",
"       </td>",
"       <td>",
"        LA - Vegetable oils (soybean, corn, cottonseed), peanut, tree nuts, seeds, other vegetable sources, poultry",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Saturated fatty acids",
"       </td>",
"       <td>",
"        Full fat or fat-reduced dairy products, meat, poultry, vegetable oils (coconut, palm kernel, palm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trans fatty acids",
"       </td>",
"       <td>",
"        Partially hydrogenated vegetable oils (stick and full-fat margarine, commercial baked goods, deep fried foods)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ALA: alpha-linolenic acid; EPA: eicosapentaenoic acid; DHA: docosahexaenoic acid; LA: linoleic acid.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18091=[""].join("\n");
var outline_f17_42_18091=null;
var title_f17_42_18092="Causes hypoglycemia";
var content_f17_42_18092=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F78919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F78919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of hypoglycemia in adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Ill or medicated individual",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        1. Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Insulin or insulin secretagogue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alcohol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Others (refer to UpToDate table on&nbsp;drugs that cause hypoglycemia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        2. Critical illnesses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatic, renal, or cardiac failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sepsis (including malaria)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Inanition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        3. Hormone deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cortisol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Glucagon and epinephrine (in insulin-deficient diabetes mellitus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        4. Nonislet cell tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Seemingly well individual",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        5. Endogenous hyperinsulinism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Insulinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Functional",
"        <sub>",
"         &beta;",
"        </sub>",
"        -cell disorders (nesidioblastosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Noninsulinoma pancreatogenous hypoglycemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Post gastric bypass hypoglycemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Insulin autoimmune hypoglycemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Antibody to insulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Antibody to insulin receptor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Insulin secretagogue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        6. Accidental, surreptitious, or malicious hypoglycemia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009; 94:709. Copyright &copy; 2009 The Endocrine Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18092=[""].join("\n");
var outline_f17_42_18092=null;
var title_f17_42_18093="ACC AHA choice imaging CHD diagnosis able to exercise";
var content_f17_42_18093=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for cardiac stress imaging as the initial test for diagnosis of coronary heart disease (CHD) in patients with chronic stable angina who are able to exercise",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Class I",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\">",
"       1. Exercise myocardial perfusion imaging or exercise echocardiography in patients with an intermediate pretest probability of CAD who have one of the following baseline ECG abnormalities:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Pre-excitation (Wolff-Parkinson-White) syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       b. More than 1 mm of ST depression at rest",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       2. Exercise myocardial perfusion imaging or exercise echocardiography in patients with prior revascularization (either PTCA or CABG).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\">",
"       3. Adenosine or dipyridamole myocardial perfusion imaging in patients with an intermediate pretest probability of CAD and one of the following baseline ECG abnormalities:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Electronically paced ventricular rhythm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       b. Left bundle-branch block",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       4. Dobutamine stress echocardiography in patients with an intermediate pretest probability of CAD and left bundle branch block.*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Class IIb",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\">",
"       1. Exercise myocardial perfusion imaging and exercise echocardiography in patients with a low or high probability of CAD who have one of the following baseline ECG abnormalities:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Pre-excitation (Wolff-Parkinson-White) syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       b. More than 1 mm of ST depression",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\">",
"       2. Adenosine or dipyridamole myocardial perfusion imaging in patients with a low or high probability of CAD and one of the following baseline ECG abnormalities:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Electronically paced ventricular rhythm b. Left bundle-branch block",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\">",
"       3. Exercise myocardial perfusion imaging or exercise echocardiography in patients with an intermediate probability of CAD who have one of the following:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Digoxin use with &lt;1 mm ST depression on the baseline ECG",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       b. LVH with &lt;1 mm ST depression on the baseline ECG",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       4. Exercise myocardial perfusion imaging, exercise echocardiography, adenosine or dipyridamole myocardial perfusion imaging or dobutamine echocardiography as the initial stress test in a patient with a normal rest ECG who is not taking digoxin.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       5. Exercise in patients with left bundle-branch block.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       ACC/AHA classification",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Class I:",
"       </strong>",
"       Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       <strong>",
"        Class II:",
"       </strong>",
"       Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Class IIa:",
"       </strong>",
"       Weight of evidence/opinion is in favor of usefulness/efficacy.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Class IIb:",
"       </strong>",
"       Usefulness/efficacy less well established by evidence/opinion.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Class III:",
"       </strong>",
"       Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful and in some cases may be harmful.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Modified from: Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:e418.",
"    </div>",
"    <div class=\"reference\">",
"     Data modified from: Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003; 107:149.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18093=[""].join("\n");
var outline_f17_42_18093=null;
var title_f17_42_18094="SVR genotype AASLD";
var content_f17_42_18094=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F56726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F56726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sustained virologic response rates with peginterferon alfa-2a (pegIFN) or interferon alfa-2b (IFN) and ribavirin (RBV) according to hepatitis C virus genotype",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 424px; height: 329px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from the American Association for the Study of Liver Diseases. Hepatology 2004; 39:1147.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18094=[""].join("\n");
var outline_f17_42_18094=null;
var title_f17_42_18095="Buckle fracture";
var content_f17_42_18095=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F59992&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F59992&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 526px\">",
"   <div class=\"ttl\">",
"    Buckle fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 506px; height: 275px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    AP and oblique views of the left forearm. Buckle (torus) fracture of the dorsolateral cortex of the distal radial metaphysis. No displacement or angulation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David Mathison, MD and Dewesh Agrawal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_42_18095=[""].join("\n");
var outline_f17_42_18095=null;
